{
  "id": "autoimmune-encephalitis",
  "title": "Autoimmune Encephalitis",
  "version": "1.0",
  "icd10": [
    "** G04.81 (Other autoimmune encephalitis)",
    "G04.90 (Encephalitis and encephalomyelitis",
    "unspecified)"
  ],
  "scope": "** Diagnostic workup, acute treatment, and long-term management of suspected or confirmed autoimmune encephalitis. Covers antibody-mediated encephalitis (anti-NMDAR, LGI1, CASPR2, GABA-B, AMPA, DPPX, IgLON5, GABA-A, GAD65), first-line immunotherapy, second-line escalation, seizure management, psychiatric symptom management, ICU considerations, tumor screening, and long-term immunosuppression. For infectious encephalitis, use \"HSV Encephalitis\" template. For paraneoplastic syndromes without encephalitis, use \"Paraneoplastic Syndrome\" template. For status epilepticus management, use \"Status Epilepticus\" template.",
  "notes": [],
  "sections": {
    "Laboratory Workup": {
      "Essential/Core Labs": [
        {
          "item": "CBC with differential (CPT 85025)",
          "ED": "STAT",
          "HOSP": "STAT",
          "OPD": "ROUTINE",
          "ICU": "STAT",
          "rationale": "Baseline; infection screen; pre-immunotherapy",
          "target": "Normal"
        },
        {
          "item": "CMP (BMP + LFTs) (CPT 80053)",
          "ED": "STAT",
          "HOSP": "STAT",
          "OPD": "ROUTINE",
          "ICU": "STAT",
          "rationale": "Metabolic screen; renal/hepatic baseline for immunotherapy",
          "target": "Normal"
        },
        {
          "item": "TSH (CPT 84443)",
          "ED": "URGENT",
          "HOSP": "ROUTINE",
          "OPD": "ROUTINE",
          "ICU": "URGENT",
          "rationale": "Thyroid encephalopathy mimic; Hashimoto encephalopathy screen",
          "target": "Normal"
        },
        {
          "item": "ESR (CPT 85652)",
          "ED": "URGENT",
          "HOSP": "ROUTINE",
          "OPD": "ROUTINE",
          "ICU": "URGENT",
          "rationale": "Inflammatory/vasculitis screen",
          "target": "Normal (<20 mm/hr)"
        },
        {
          "item": "CRP (CPT 86140)",
          "ED": "URGENT",
          "HOSP": "ROUTINE",
          "OPD": "ROUTINE",
          "ICU": "URGENT",
          "rationale": "Inflammatory marker; infection screen",
          "target": "Normal"
        },
        {
          "item": "Urinalysis with culture (CPT 81003+87086)",
          "ED": "STAT",
          "HOSP": "STAT",
          "OPD": "ROUTINE",
          "ICU": "STAT",
          "rationale": "UTI as encephalopathy trigger",
          "target": "Negative"
        },
        {
          "item": "Blood cultures (x2 sets) (CPT 87040)",
          "ED": "STAT",
          "HOSP": "STAT",
          "OPD": "-",
          "ICU": "STAT",
          "rationale": "Rule out septic encephalopathy",
          "target": "No growth"
        },
        {
          "item": "Blood glucose (CPT 82947)",
          "ED": "STAT",
          "HOSP": "STAT",
          "OPD": "ROUTINE",
          "ICU": "STAT",
          "rationale": "Metabolic encephalopathy screen; pre-steroid baseline",
          "target": "Normal"
        },
        {
          "item": "HbA1c (CPT 83036)",
          "ED": "-",
          "HOSP": "ROUTINE",
          "OPD": "ROUTINE",
          "ICU": "-",
          "rationale": "Glycemic status before high-dose steroids",
          "target": "<5.7%"
        },
        {
          "item": "Ammonia (CPT 82140)",
          "ED": "STAT",
          "HOSP": "STAT",
          "OPD": "-",
          "ICU": "STAT",
          "rationale": "Hepatic encephalopathy mimic",
          "target": "Normal"
        },
        {
          "item": "Lactate (CPT 83605)",
          "ED": "STAT",
          "HOSP": "STAT",
          "OPD": "-",
          "ICU": "STAT",
          "rationale": "Sepsis screen; metabolic screen",
          "target": "Normal (<2.0 mmol/L)"
        },
        {
          "item": "PT/INR, aPTT (CPT 85610+85730)",
          "ED": "STAT",
          "HOSP": "STAT",
          "OPD": "-",
          "ICU": "STAT",
          "rationale": "Coagulopathy screen pre-LP; DIC screen",
          "target": "Normal"
        },
        {
          "item": "Magnesium (CPT 83735)",
          "ED": "STAT",
          "HOSP": "STAT",
          "OPD": "ROUTINE",
          "ICU": "STAT",
          "rationale": "Seizure threshold; metabolic screen",
          "target": "Normal"
        },
        {
          "item": "Phosphorus (CPT 84100)",
          "ED": "STAT",
          "HOSP": "STAT",
          "OPD": "-",
          "ICU": "STAT",
          "rationale": "Metabolic screen",
          "target": "Normal"
        },
        {
          "item": "Procalcitonin (CPT 84145)",
          "ED": "URGENT",
          "HOSP": "URGENT",
          "OPD": "-",
          "ICU": "URGENT",
          "rationale": "Distinguish bacterial vs autoimmune etiology",
          "target": "Normal (<0.1 ng/mL)"
        },
        {
          "item": "Troponin (CPT 84484)",
          "ED": "STAT",
          "HOSP": "STAT",
          "OPD": "-",
          "ICU": "STAT",
          "rationale": "Cardiac involvement; autonomic instability assessment",
          "target": "Normal"
        },
        {
          "item": "CPK (CPT 82550)",
          "ED": "URGENT",
          "HOSP": "URGENT",
          "OPD": "-",
          "ICU": "URGENT",
          "rationale": "Rhabdomyolysis from prolonged seizures/catatonia",
          "target": "Normal"
        },
        {
          "item": "Urine drug screen (CPT 80307)",
          "ED": "STAT",
          "HOSP": "STAT",
          "OPD": "-",
          "ICU": "STAT",
          "rationale": "Toxic/drug-induced encephalopathy mimic",
          "target": "Negative"
        },
        {
          "item": "Alcohol level (CPT 80320)",
          "ED": "STAT",
          "HOSP": "STAT",
          "OPD": "-",
          "ICU": "STAT",
          "rationale": "Alcohol-related encephalopathy",
          "target": "Negative"
        },
        {
          "item": "Pregnancy test (females of childbearing age) (CPT 81025)",
          "ED": "STAT",
          "HOSP": "STAT",
          "OPD": "ROUTINE",
          "ICU": "STAT",
          "rationale": "Eclampsia mimic; treatment planning (teratogenicity)",
          "target": "As applicable"
        },
        {
          "item": "Peripheral blood smear",
          "ED": "URGENT",
          "HOSP": "URGENT",
          "OPD": "-",
          "ICU": "URGENT",
          "rationale": "TTP/HUS screen if thrombocytopenia",
          "target": "Normal"
        },
        {
          "item": "LDH (CPT 83615)",
          "ED": "URGENT",
          "HOSP": "ROUTINE",
          "OPD": "ROUTINE",
          "ICU": "URGENT",
          "rationale": "Hemolysis screen; tumor marker",
          "target": "Normal"
        },
        {
          "item": "Uric acid",
          "ED": "-",
          "HOSP": "ROUTINE",
          "OPD": "ROUTINE",
          "ICU": "-",
          "rationale": "Tumor lysis risk if malignancy suspected",
          "target": "Normal"
        },
        {
          "item": "Lipase",
          "ED": "STAT",
          "HOSP": "STAT",
          "OPD": "-",
          "ICU": "STAT",
          "rationale": "Pancreatitis-related encephalopathy",
          "target": "Normal"
        }
      ],
      "Autoimmune Antibody Panel": [
        {
          "item": "**Anti-NMDAR antibody (serum AND CSF)** (CPT 86255)",
          "ED": "URGENT",
          "HOSP": "URGENT",
          "OPD": "ROUTINE",
          "ICU": "URGENT",
          "rationale": "Most common autoimmune encephalitis; CSF more sensitive than serum; cell-based assay (CBA) preferred",
          "target": "Negative"
        },
        {
          "item": "**Anti-LGI1 antibody (serum AND CSF)** (CPT 86235)",
          "ED": "URGENT",
          "HOSP": "URGENT",
          "OPD": "ROUTINE",
          "ICU": "URGENT",
          "rationale": "Limbic encephalitis; faciobrachial dystonic seizures (FBDS); hyponatremia",
          "target": "Negative"
        },
        {
          "item": "**Anti-CASPR2 antibody (serum AND CSF)** (CPT 86235)",
          "ED": "URGENT",
          "HOSP": "URGENT",
          "OPD": "ROUTINE",
          "ICU": "URGENT",
          "rationale": "Limbic encephalitis; Morvan syndrome; neuromyotonia; neuropathic pain",
          "target": "Negative"
        },
        {
          "item": "**Anti-GABA-B antibody (serum AND CSF)**",
          "ED": "URGENT",
          "HOSP": "URGENT",
          "OPD": "ROUTINE",
          "ICU": "URGENT",
          "rationale": "Limbic encephalitis with prominent seizures; 50% associated with SCLC",
          "target": "Negative"
        },
        {
          "item": "**Anti-AMPA antibody (serum AND CSF)**",
          "ED": "URGENT",
          "HOSP": "URGENT",
          "OPD": "ROUTINE",
          "ICU": "URGENT",
          "rationale": "Limbic encephalitis; relapsing course; associated with thymoma, lung, breast",
          "target": "Negative"
        },
        {
          "item": "**Anti-DPPX antibody (serum AND CSF)**",
          "ED": "URGENT",
          "HOSP": "URGENT",
          "OPD": "ROUTINE",
          "ICU": "URGENT",
          "rationale": "Encephalitis with hyperexcitability, GI symptoms, PERM",
          "target": "Negative"
        },
        {
          "item": "**Anti-IgLON5 antibody (serum AND CSF)**",
          "ED": "-",
          "HOSP": "URGENT",
          "OPD": "ROUTINE",
          "ICU": "URGENT",
          "rationale": "Sleep disorder, bulbar dysfunction, gait instability, tau pathology",
          "target": "Negative"
        },
        {
          "item": "**Anti-GABA-A antibody (serum AND CSF)**",
          "ED": "-",
          "HOSP": "URGENT",
          "OPD": "ROUTINE",
          "ICU": "URGENT",
          "rationale": "Refractory seizures/status epilepticus; often with thymoma",
          "target": "Negative"
        },
        {
          "item": "**Anti-GAD65 antibody (serum AND CSF)**",
          "ED": "URGENT",
          "HOSP": "URGENT",
          "OPD": "ROUTINE",
          "ICU": "URGENT",
          "rationale": "Limbic encephalitis, stiff-person spectrum, cerebellar ataxia; high titers (>20 nmol/L) significant",
          "target": "Negative or low titer"
        },
        {
          "item": "**Mayo Autoimmune Evaluation - Encephalopathy (serum)**",
          "ED": "URGENT",
          "HOSP": "URGENT",
          "OPD": "ROUTINE",
          "ICU": "URGENT",
          "rationale": "Comprehensive panel: NMDAR, LGI1, CASPR2, GABA-B, AMPA, DPPX",
          "target": "All negative"
        },
        {
          "item": "**Mayo Autoimmune Evaluation - Encephalopathy (CSF)**",
          "ED": "URGENT",
          "HOSP": "URGENT",
          "OPD": "ROUTINE",
          "ICU": "URGENT",
          "rationale": "CSF panel: NMDAR, LGI1, CASPR2, GABA-B, AMPA, DPPX",
          "target": "All negative"
        },
        {
          "item": "ANA (CPT 86235)",
          "ED": "URGENT",
          "HOSP": "ROUTINE",
          "OPD": "ROUTINE",
          "ICU": "URGENT",
          "rationale": "Lupus cerebritis screen",
          "target": "Negative or low titer"
        },
        {
          "item": "Anti-dsDNA",
          "ED": "-",
          "HOSP": "ROUTINE",
          "OPD": "ROUTINE",
          "ICU": "-",
          "rationale": "If ANA positive; lupus evaluation",
          "target": "Negative"
        },
        {
          "item": "Anti-SSA/SSB (Ro/La)",
          "ED": "-",
          "HOSP": "ROUTINE",
          "OPD": "ROUTINE",
          "ICU": "-",
          "rationale": "Sjogren syndrome with CNS involvement",
          "target": "Negative"
        },
        {
          "item": "Anti-TPO antibodies",
          "ED": "URGENT",
          "HOSP": "ROUTINE",
          "OPD": "ROUTINE",
          "ICU": "URGENT",
          "rationale": "Hashimoto encephalopathy (SREAT)",
          "target": "Negative"
        },
        {
          "item": "Anti-thyroglobulin antibodies",
          "ED": "URGENT",
          "HOSP": "ROUTINE",
          "OPD": "ROUTINE",
          "ICU": "URGENT",
          "rationale": "Hashimoto encephalopathy (SREAT)",
          "target": "Negative"
        },
        {
          "item": "AQP4-IgG (NMO antibody)",
          "ED": "-",
          "HOSP": "ROUTINE",
          "OPD": "ROUTINE",
          "ICU": "-",
          "rationale": "NMOSD overlap; cell-based assay preferred",
          "target": "Negative"
        },
        {
          "item": "MOG-IgG",
          "ED": "-",
          "HOSP": "ROUTINE",
          "OPD": "ROUTINE",
          "ICU": "-",
          "rationale": "MOGAD overlap; ADEM-like presentation",
          "target": "Negative"
        },
        {
          "item": "Complement C3, C4",
          "ED": "-",
          "HOSP": "ROUTINE",
          "OPD": "ROUTINE",
          "ICU": "-",
          "rationale": "Lupus; complement-mediated disease",
          "target": "Normal"
        },
        {
          "item": "Quantitative immunoglobulins (IgG, IgA, IgM)",
          "ED": "-",
          "HOSP": "ROUTINE",
          "OPD": "ROUTINE",
          "ICU": "-",
          "rationale": "Baseline before immunotherapy; IgA deficiency (IVIG contraindication)",
          "target": "Normal"
        }
      ],
      "Rare/Specialized (Refractory or Atypical)": [
        {
          "item": "Anti-neuronal nuclear antibody type 1 (ANNA-1/anti-Hu)",
          "ED": "-",
          "HOSP": "EXT",
          "OPD": "EXT",
          "ICU": "-",
          "rationale": "Paraneoplastic; SCLC, neuroblastoma",
          "target": "Negative"
        },
        {
          "item": "Anti-neuronal nuclear antibody type 2 (ANNA-2/anti-Ri)",
          "ED": "-",
          "HOSP": "EXT",
          "OPD": "EXT",
          "ICU": "-",
          "rationale": "Paraneoplastic; breast, SCLC",
          "target": "Negative"
        },
        {
          "item": "Anti-CV2/CRMP5",
          "ED": "-",
          "HOSP": "EXT",
          "OPD": "EXT",
          "ICU": "-",
          "rationale": "Paraneoplastic; SCLC, thymoma",
          "target": "Negative"
        },
        {
          "item": "Anti-amphiphysin",
          "ED": "-",
          "HOSP": "EXT",
          "OPD": "EXT",
          "ICU": "-",
          "rationale": "Paraneoplastic; breast, SCLC; stiff-person overlap",
          "target": "Negative"
        },
        {
          "item": "Anti-Ma2/Ta",
          "ED": "-",
          "HOSP": "EXT",
          "OPD": "EXT",
          "ICU": "-",
          "rationale": "Paraneoplastic limbic encephalitis; testicular germ cell tumor",
          "target": "Negative"
        },
        {
          "item": "Anti-SOX1",
          "ED": "-",
          "HOSP": "EXT",
          "OPD": "EXT",
          "ICU": "-",
          "rationale": "SCLC-associated; Lambert-Eaton overlap",
          "target": "Negative"
        },
        {
          "item": "Anti-Kelch-like protein 11 (KLHL11)",
          "ED": "-",
          "HOSP": "EXT",
          "OPD": "EXT",
          "ICU": "-",
          "rationale": "Testicular seminoma; brainstem/cerebellar syndrome",
          "target": "Negative"
        },
        {
          "item": "Anti-GlyR (glycine receptor)",
          "ED": "-",
          "HOSP": "EXT",
          "OPD": "EXT",
          "ICU": "-",
          "rationale": "Progressive encephalomyelitis with rigidity and myoclonus (PERM)",
          "target": "Negative"
        },
        {
          "item": "Anti-mGluR5",
          "ED": "-",
          "HOSP": "EXT",
          "OPD": "EXT",
          "ICU": "-",
          "rationale": "Ophelia syndrome; Hodgkin lymphoma",
          "target": "Negative"
        },
        {
          "item": "Anti-mGluR1",
          "ED": "-",
          "HOSP": "EXT",
          "OPD": "EXT",
          "ICU": "-",
          "rationale": "Cerebellar ataxia; Hodgkin lymphoma",
          "target": "Negative"
        },
        {
          "item": "Anti-neurexin-3-alpha",
          "ED": "-",
          "HOSP": "EXT",
          "OPD": "EXT",
          "ICU": "-",
          "rationale": "Rapid-onset encephalitis; seizures; confusion",
          "target": "Negative"
        },
        {
          "item": "Anti-D2R (dopamine-2 receptor)",
          "ED": "-",
          "HOSP": "EXT",
          "OPD": "EXT",
          "ICU": "-",
          "rationale": "Basal ganglia encephalitis; movement disorders",
          "target": "Negative"
        },
        {
          "item": "Paraneoplastic evaluation panel (comprehensive)",
          "ED": "-",
          "HOSP": "EXT",
          "OPD": "EXT",
          "ICU": "-",
          "rationale": "If standard panels negative and paraneoplastic suspected",
          "target": "All negative"
        },
        {
          "item": "14-3-3 protein (CSF)",
          "ED": "-",
          "HOSP": "EXT",
          "OPD": "EXT",
          "ICU": "-",
          "rationale": "Prion disease mimic; rapidly progressive dementia",
          "target": "Negative"
        },
        {
          "item": "RT-QuIC (CSF)",
          "ED": "-",
          "HOSP": "EXT",
          "OPD": "EXT",
          "ICU": "-",
          "rationale": "Prion disease exclusion in rapidly progressive cases",
          "target": "Negative"
        },
        {
          "item": "Next-generation sequencing (CSF metagenomics)",
          "ED": "-",
          "HOSP": "EXT",
          "OPD": "EXT",
          "ICU": "-",
          "rationale": "Occult infection when standard testing negative",
          "target": "No pathogens detected"
        }
      ],
      "Lumbar Puncture": [
        {
          "item": "Opening pressure",
          "ED": "URGENT",
          "HOSP": "ROUTINE",
          "OPD": "ROUTINE",
          "rationale": "Elevated ICP assessment",
          "target": "10-20 cm H2O"
        },
        {
          "item": "Cell count with differential (tubes 1 and 4) (CPT 89051)",
          "ED": "STAT",
          "HOSP": "STAT",
          "OPD": "ROUTINE",
          "rationale": "Lymphocytic pleocytosis supports autoimmune",
          "target": "WBC 5-80 (lymphocyte-predominant); RBC 0"
        },
        {
          "item": "Protein (CPT 84157)",
          "ED": "STAT",
          "HOSP": "STAT",
          "OPD": "ROUTINE",
          "rationale": "Mildly elevated in autoimmune; markedly elevated suggests infection/GBS",
          "target": "Normal to mildly elevated (usually <100 mg/dL)"
        },
        {
          "item": "Glucose with paired serum glucose (CPT 82945)",
          "ED": "STAT",
          "HOSP": "STAT",
          "OPD": "ROUTINE",
          "rationale": "Low in infection/carcinomatous meningitis",
          "target": "Normal (>60% of serum)"
        },
        {
          "item": "Gram stain and bacterial culture (CPT 87205+87070)",
          "ED": "STAT",
          "HOSP": "STAT",
          "OPD": "ROUTINE",
          "rationale": "Rule out bacterial meningitis",
          "target": "No organisms"
        },
        {
          "item": "HSV 1/2 PCR (CPT 87529)",
          "ED": "STAT",
          "HOSP": "STAT",
          "OPD": "ROUTINE",
          "rationale": "Rule out HSV encephalitis (most important mimic)",
          "target": "Negative"
        },
        {
          "item": "VZV PCR",
          "ED": "URGENT",
          "HOSP": "URGENT",
          "OPD": "ROUTINE",
          "rationale": "Varicella encephalitis",
          "target": "Negative"
        },
        {
          "item": "EBV PCR",
          "ED": "-",
          "HOSP": "ROUTINE",
          "OPD": "ROUTINE",
          "rationale": "EBV-associated encephalitis; lymphoma screen",
          "target": "Negative"
        },
        {
          "item": "CMV PCR",
          "ED": "-",
          "HOSP": "ROUTINE",
          "OPD": "ROUTINE",
          "rationale": "Immunocompromised patients",
          "target": "Negative"
        },
        {
          "item": "HHV-6 PCR",
          "ED": "-",
          "HOSP": "ROUTINE",
          "OPD": "ROUTINE",
          "rationale": "Post-transplant; limbic encephalitis mimic",
          "target": "Negative"
        },
        {
          "item": "Enterovirus PCR",
          "ED": "URGENT",
          "HOSP": "URGENT",
          "OPD": "-",
          "rationale": "Viral meningitis/encephalitis",
          "target": "Negative"
        },
        {
          "item": "West Nile virus IgM/IgG",
          "ED": "-",
          "HOSP": "ROUTINE",
          "OPD": "-",
          "rationale": "Endemic areas; flaccid paralysis",
          "target": "Negative"
        },
        {
          "item": "Cryptococcal antigen (CPT 87327)",
          "ED": "URGENT",
          "HOSP": "ROUTINE",
          "OPD": "-",
          "rationale": "Immunocompromised; chronic meningitis",
          "target": "Negative"
        },
        {
          "item": "VDRL (CSF) (CPT 86592)",
          "ED": "-",
          "HOSP": "ROUTINE",
          "OPD": "ROUTINE",
          "rationale": "Neurosyphilis",
          "target": "Negative"
        },
        {
          "item": "Oligoclonal bands (CSF AND paired serum) (CPT 83916)",
          "ED": "URGENT",
          "HOSP": "ROUTINE",
          "OPD": "ROUTINE",
          "rationale": "Intrathecal IgG synthesis; MS/NMOSD overlap",
          "target": "May show CSF-specific bands"
        },
        {
          "item": "IgG index",
          "ED": "URGENT",
          "HOSP": "ROUTINE",
          "OPD": "ROUTINE",
          "rationale": "Intrathecal antibody synthesis",
          "target": "May be elevated"
        },
        {
          "item": "Cytology (CPT 88104)",
          "ED": "-",
          "HOSP": "ROUTINE",
          "OPD": "ROUTINE",
          "rationale": "Carcinomatous/lymphomatous meningitis",
          "target": "Negative"
        },
        {
          "item": "Flow cytometry",
          "ED": "-",
          "HOSP": "ROUTINE",
          "OPD": "ROUTINE",
          "rationale": "CNS lymphoma",
          "target": "Normal"
        },
        {
          "item": "**Autoimmune encephalitis antibody panel (CSF)**",
          "ED": "URGENT",
          "HOSP": "URGENT",
          "OPD": "ROUTINE",
          "rationale": "NMDAR, LGI1, CASPR2, GABA-B, AMPA, DPPX -- CBA method",
          "target": "All negative"
        },
        {
          "item": "**Anti-NMDAR IgG (CSF)**",
          "ED": "URGENT",
          "HOSP": "URGENT",
          "OPD": "ROUTINE",
          "rationale": "CSF more sensitive than serum for NMDAR",
          "target": "Negative"
        },
        {
          "item": "AFB culture and smear (CPT 87116)",
          "ED": "-",
          "HOSP": "ROUTINE",
          "OPD": "-",
          "rationale": "TB meningitis if risk factors",
          "target": "Negative"
        },
        {
          "item": "Fungal culture (CPT 87102)",
          "ED": "-",
          "HOSP": "ROUTINE",
          "OPD": "-",
          "rationale": "Immunocompromised",
          "target": "Negative"
        }
      ]
    },
    "Imaging & Studies": {
      "Essential/First-line": [
        {
          "item": "CT head without contrast (CPT 70450)",
          "ED": "STAT",
          "HOSP": "STAT",
          "OPD": "-",
          "ICU": "STAT",
          "timing": "Immediate (ED triage)",
          "target": "Rule out mass, hemorrhage, hydrocephalus",
          "contraindications": "None significant"
        },
        {
          "item": "MRI brain with and without contrast (CPT 70553)",
          "ED": "URGENT",
          "HOSP": "URGENT",
          "OPD": "ROUTINE",
          "ICU": "URGENT",
          "timing": "Within 24h",
          "target": "Mesial temporal T2/FLAIR hyperintensity (limbic encephalitis); cortical/subcortical signal changes; leptomeningeal enhancement",
          "contraindications": "GFR <30, gadolinium allergy, pacemaker"
        },
        {
          "item": "EEG (routine or continuous) (CPT 95816)",
          "ED": "URGENT",
          "HOSP": "URGENT",
          "OPD": "ROUTINE",
          "ICU": "STAT",
          "timing": "Within 24h; continuous if ICU or altered consciousness",
          "target": "Extreme delta brush (anti-NMDAR); focal/generalized slowing; epileptiform discharges; subclinical seizures",
          "contraindications": "None significant"
        },
        {
          "item": "ECG (12-lead) (CPT 93000)",
          "ED": "STAT",
          "HOSP": "STAT",
          "OPD": "ROUTINE",
          "ICU": "STAT",
          "timing": "Immediate",
          "target": "Autonomic dysfunction; arrhythmia; QTc prolongation (medication safety)",
          "contraindications": "None"
        },
        {
          "item": "Chest X-ray (CPT 71046)",
          "ED": "STAT",
          "HOSP": "STAT",
          "OPD": "-",
          "ICU": "STAT",
          "timing": "Immediate",
          "target": "Mediastinal mass (thymoma); pulmonary mass (SCLC)",
          "contraindications": "Pregnancy (relative)"
        },
        {
          "item": "Continuous telemetry",
          "ED": "-",
          "HOSP": "STAT",
          "OPD": "-",
          "ICU": "STAT",
          "timing": "Continuous in hospital",
          "target": "Arrhythmia from autonomic instability",
          "contraindications": "None"
        }
      ],
      "Extended": [
        {
          "item": "MRI spine (cervical and thoracic) with and without contrast",
          "ED": "-",
          "HOSP": "ROUTINE",
          "OPD": "ROUTINE",
          "ICU": "ROUTINE",
          "timing": "Within 48-72h",
          "target": "Concurrent myelitis; overlap syndromes",
          "contraindications": "GFR <30, gadolinium allergy"
        },
        {
          "item": "CT chest/abdomen/pelvis with contrast (CPT 71260+74178)",
          "ED": "-",
          "HOSP": "URGENT",
          "OPD": "ROUTINE",
          "ICU": "URGENT",
          "timing": "Within 48h",
          "target": "Occult malignancy: thymoma, lung cancer, ovarian teratoma, lymphoma",
          "contraindications": "Contrast allergy, renal insufficiency"
        },
        {
          "item": "Pelvic/transvaginal ultrasound (females)",
          "ED": "-",
          "HOSP": "URGENT",
          "OPD": "ROUTINE",
          "ICU": "URGENT",
          "timing": "Within 48h",
          "target": "Ovarian teratoma (anti-NMDAR)",
          "contraindications": "None significant"
        },
        {
          "item": "Testicular ultrasound (males <50)",
          "ED": "-",
          "HOSP": "URGENT",
          "OPD": "ROUTINE",
          "ICU": "URGENT",
          "timing": "Within 48h",
          "target": "Testicular germ cell tumor (anti-Ma2, KLHL11)",
          "contraindications": "None significant"
        },
        {
          "item": "FDG-PET/CT (whole body) (CPT 78816)",
          "ED": "-",
          "HOSP": "ROUTINE",
          "OPD": "ROUTINE",
          "ICU": "-",
          "timing": "Within 1-2 weeks",
          "target": "Occult malignancy not seen on CT; FDG-avid tumor",
          "contraindications": "Uncontrolled diabetes, pregnancy"
        },
        {
          "item": "Video-EEG monitoring (prolonged)",
          "ED": "-",
          "HOSP": "ROUTINE",
          "OPD": "ROUTINE",
          "ICU": "STAT",
          "timing": "As needed",
          "target": "Characterize seizure semiology; subclinical seizures; extreme delta brush pattern",
          "contraindications": "None"
        },
        {
          "item": "FDG-PET brain",
          "ED": "-",
          "HOSP": "EXT",
          "OPD": "EXT",
          "ICU": "-",
          "timing": "Within 1-2 weeks",
          "target": "Mesial temporal hypermetabolism (early) or hypometabolism (late); cortical metabolic changes",
          "contraindications": "Same as PET/CT"
        }
      ],
      "Rare/Specialized": [
        {
          "item": "MRI brain with epilepsy protocol",
          "ED": "-",
          "HOSP": "EXT",
          "OPD": "EXT",
          "ICU": "-",
          "timing": "If seizures refractory",
          "target": "Subtle cortical lesions; hippocampal sclerosis",
          "contraindications": "Gadolinium contraindications"
        },
        {
          "item": "Brain biopsy",
          "ED": "-",
          "HOSP": "EXT",
          "OPD": "-",
          "ICU": "-",
          "timing": "Last resort",
          "target": "Inflammatory infiltrate; exclusion of other pathology",
          "contraindications": "Coagulopathy, inaccessible location"
        },
        {
          "item": "CT-guided biopsy (tumor)",
          "ED": "-",
          "HOSP": "EXT",
          "OPD": "EXT",
          "ICU": "-",
          "timing": "After tumor identified",
          "target": "Histopathological confirmation",
          "contraindications": "Coagulopathy, tumor location"
        },
        {
          "item": "Mammography/breast MRI",
          "ED": "-",
          "HOSP": "ROUTINE",
          "OPD": "ROUTINE",
          "ICU": "-",
          "timing": "If AMPA, amphiphysin positive",
          "target": "Breast malignancy",
          "contraindications": "Implants (relative for MRI)"
        },
        {
          "item": "Polysomnography",
          "ED": "-",
          "HOSP": "-",
          "OPD": "EXT",
          "ICU": "-",
          "timing": "If IgLON5 suspected",
          "target": "REM/NREM parasomnias; sleep disordered breathing",
          "contraindications": "None significant"
        }
      ]
    },
    "Treatment": {
      "Acute/Emergent": [
        {
          "item": "Empiric acyclovir IV (until HSV ruled out)",
          "route": "IV",
          "indication": "-",
          "dosing": {
            "doseOptions": [
              {
                "text": "10 mg/kg",
                "orderSentence": "Empiric acyclovir IV (until HSV ruled out) 10 mg/kg IV"
              }
            ],
            "route": "IV",
            "instructions": "10 mg/kg IV q8h; continue until HSV PCR negative x2 (48h apart) or alternative diagnosis confirmed",
            "orderSentence": "Empiric acyclovir IV (until HSV ruled out) 10 mg/kg IV"
          },
          "contraindications": "Renal impairment (adjust dose); adequate hydration required",
          "monitoring": "Renal function daily; hydration status; crystal nephropathy prevention",
          "ED": "STAT",
          "HOSP": "STAT",
          "OPD": "-",
          "ICU": "STAT"
        },
        {
          "item": "Empiric antibiotics (if bacterial meningitis not excluded)",
          "route": "IV",
          "indication": "-",
          "dosing": {
            "doseOptions": [
              {
                "text": "2g",
                "orderSentence": "Empiric antibiotics (if bacterial meningitis not excluded) 2g IV"
              }
            ],
            "route": "IV",
            "instructions": "Ceftriaxone 2g IV q12h + vancomycin 15-20 mg/kg IV q8-12h + dexamethasone 0.15 mg/kg q6h x 4 days",
            "orderSentence": "Empiric antibiotics (if bacterial meningitis not excluded) 2g IV"
          },
          "contraindications": "Per individual drug allergies",
          "monitoring": "Cultures; clinical response; renal function; vancomycin troughs",
          "ED": "STAT",
          "HOSP": "STAT",
          "OPD": "-",
          "ICU": "STAT"
        },
        {
          "item": "Lorazepam (acute seizure)",
          "route": "IV",
          "indication": "-",
          "dosing": {
            "doseOptions": [
              {
                "text": "0.5 mg TID",
                "orderSentence": "Lorazepam 0.5 mg IV TID"
              },
              {
                "text": "1 mg TID",
                "orderSentence": "Lorazepam 1 mg IV TID"
              },
              {
                "text": "2 mg TID",
                "orderSentence": "Lorazepam 2 mg IV TID"
              }
            ],
            "route": "IV",
            "instructions": "0.1 mg/kg IV (max 4 mg/dose); may repeat x1 in 5 minutes",
            "orderSentence": "Lorazepam 0.5 mg IV TID"
          },
          "contraindications": "Respiratory depression; acute narrow-angle glaucoma",
          "monitoring": "Respiratory status; sedation level; airway patency",
          "ED": "STAT",
          "HOSP": "STAT",
          "OPD": "-",
          "ICU": "STAT"
        },
        {
          "item": "Midazolam (if no IV access)",
          "route": "IV",
          "indication": "-",
          "dosing": {
            "doseOptions": [
              {
                "text": "2 mg once",
                "orderSentence": "Midazolam 2 mg IM once"
              },
              {
                "text": "5 mg once",
                "orderSentence": "Midazolam 5 mg IM once"
              },
              {
                "text": "10 mg once",
                "orderSentence": "Midazolam 10 mg IM once"
              }
            ],
            "route": "IM",
            "instructions": "10 mg IM (adults >40 kg) or 0.2 mg/kg intranasal",
            "orderSentence": "Midazolam 2 mg IM once"
          },
          "contraindications": "Respiratory depression",
          "monitoring": "Same as lorazepam",
          "ED": "STAT",
          "HOSP": "STAT",
          "OPD": "-",
          "ICU": "STAT"
        },
        {
          "item": "Lorazepam (catatonia challenge)",
          "route": "IV",
          "indication": "-",
          "dosing": {
            "doseOptions": [
              {
                "text": "0.5 mg TID",
                "orderSentence": "Lorazepam 0.5 mg IV TID"
              },
              {
                "text": "1 mg TID",
                "orderSentence": "Lorazepam 1 mg IV TID"
              },
              {
                "text": "2 mg TID",
                "orderSentence": "Lorazepam 2 mg IV TID"
              }
            ],
            "route": "IV",
            "instructions": "1-2 mg IV; observe 15-30 min for response; if improvement, continue 1-2 mg IV/PO q4-8h (up to 8-24 mg/day)",
            "orderSentence": "Lorazepam 0.5 mg IV TID"
          },
          "contraindications": "Respiratory compromise; prior paradoxical response",
          "monitoring": "Bush-Francis Catatonia Rating Scale; respiratory status; sedation",
          "ED": "STAT",
          "HOSP": "STAT",
          "OPD": "-",
          "ICU": "STAT"
        }
      ],
      "First-Line Immunotherapy": [
        {
          "item": "Methylprednisolone IV (CPT 96365)",
          "route": "IV",
          "indication": "-",
          "dosing": {
            "doseOptions": [
              {
                "text": "250 mg daily",
                "orderSentence": "Methylprednisolone Iv 250 mg IV daily"
              },
              {
                "text": "500 mg daily",
                "orderSentence": "Methylprednisolone Iv 500 mg IV daily"
              },
              {
                "text": "1000 mg daily x3-5 days",
                "orderSentence": "Methylprednisolone Iv 1000 mg IV daily x3-5 days"
              }
            ],
            "route": "IV",
            "instructions": "1000 mg IV daily x 5 days; infuse over 1-2 hours",
            "orderSentence": "Methylprednisolone Iv 250 mg IV daily"
          },
          "contraindications": "Active untreated infection; uncontrolled diabetes; psychosis from steroids",
          "monitoring": "Glucose q6h (target <180); BP; mood/sleep; I/O; GI prophylaxis",
          "ED": "URGENT",
          "HOSP": "STAT",
          "OPD": "-",
          "ICU": "STAT"
        },
        {
          "item": "Omeprazole (GI prophylaxis during steroids)",
          "route": "IV",
          "indication": "-",
          "dosing": {
            "doseOptions": [
              {
                "text": "20 mg daily",
                "orderSentence": "Omeprazole 20 mg IV daily"
              },
              {
                "text": "40 mg daily",
                "orderSentence": "Omeprazole 40 mg IV daily"
              }
            ],
            "route": "IV",
            "instructions": "40 mg IV/PO daily during steroid course",
            "orderSentence": "Omeprazole 20 mg IV daily"
          },
          "contraindications": "PPI allergy",
          "monitoring": "None routine",
          "ED": "URGENT",
          "HOSP": "STAT",
          "OPD": "-",
          "ICU": "STAT"
        },
        {
          "item": "Insulin sliding scale",
          "route": "-",
          "indication": "-",
          "dosing": {
            "doseOptions": [
              {
                "text": "180 mg",
                "orderSentence": "Insulin sliding scale 180 mg -"
              }
            ],
            "route": "-",
            "instructions": "Per protocol if glucose >180 mg/dL",
            "orderSentence": "Insulin sliding scale 180 mg -"
          },
          "contraindications": "Hypoglycemia risk",
          "monitoring": "Glucose q6h; adjust per response",
          "ED": "URGENT",
          "HOSP": "STAT",
          "OPD": "-",
          "ICU": "STAT"
        },
        {
          "item": "IVIG (intravenous immunoglobulin) (CPT 96365)",
          "route": "IV",
          "indication": "-",
          "dosing": {
            "doseOptions": [
              {
                "text": "0.4 g/kg daily x5 days",
                "orderSentence": "Ivig 0.4 g/kg IV daily x5 days"
              },
              {
                "text": "1 g/kg daily x2 days",
                "orderSentence": "Ivig 1 g/kg IV daily x2 days"
              },
              {
                "text": "2 g/kg divided over 2-5 days",
                "orderSentence": "Ivig 2 g/kg IV divided over 2-5 days"
              }
            ],
            "route": "IV",
            "instructions": "0.4 g/kg/day IV x 5 days (total 2 g/kg); infuse per weight-based protocol; premedicate with acetaminophen, diphenhydramine",
            "orderSentence": "Ivig 0.4 g/kg IV daily x5 days"
          },
          "contraindications": "IgA deficiency (anaphylaxis risk); recent thromboembolic event; renal failure",
          "monitoring": "Renal function daily; headache (aseptic meningitis); thrombosis; volume overload; check IgA level before first dose",
          "ED": "-",
          "HOSP": "STAT",
          "OPD": "-",
          "ICU": "STAT"
        },
        {
          "item": "Plasmapheresis (PLEX)",
          "route": "-",
          "indication": "-",
          "dosing": {
            "doseOptions": [
              {
                "text": "N/A",
                "orderSentence": "Plasmapheresis (PLEX) N/A -"
              }
            ],
            "route": "-",
            "instructions": "5-7 exchanges over 10-14 days; 1-1.5 plasma volumes per exchange; albumin replacement",
            "orderSentence": "Plasmapheresis (PLEX) N/A -"
          },
          "contraindications": "Hemodynamic instability; sepsis; coagulopathy; poor vascular access",
          "monitoring": "BP during exchanges; electrolytes (Ca, K, Mg); coagulation (fibrinogen); line site; citrate reactions",
          "ED": "-",
          "HOSP": "STAT",
          "OPD": "-",
          "ICU": "STAT"
        }
      ],
      "Second-Line Immunotherapy": [
        {
          "item": "Rituximab",
          "route": "IV",
          "indication": "-",
          "dosing": {
            "doseOptions": [
              {
                "text": "375 mg/m2 weekly x4",
                "orderSentence": "Rituximab 375 mg/m2 IV weekly x4"
              },
              {
                "text": "500 mg q6mo",
                "orderSentence": "Rituximab 500 mg IV q6mo"
              },
              {
                "text": "1000 mg q6mo",
                "orderSentence": "Rituximab 1000 mg IV q6mo"
              }
            ],
            "route": "IV",
            "instructions": "375 mg/m2 IV weekly x 4 doses OR 1000 mg IV x 2 doses (day 0 and day 14); premedicate with methylprednisolone 100 mg, acetaminophen, diphenhydramine",
            "orderSentence": "Rituximab 375 mg/m2 IV weekly x4"
          },
          "contraindications": "Active hepatitis B; severe active infection; live vaccines within 4 weeks",
          "monitoring": "Hepatitis B serology (before first dose); CBC with differential q2-4 weeks; immunoglobulin levels q3 months; CD19/CD20 B-cell counts; infusion reactions; PML surveillance",
          "ED": "-",
          "HOSP": "URGENT",
          "OPD": "ROUTINE",
          "ICU": "URGENT"
        },
        {
          "item": "Cyclophosphamide",
          "route": "IV",
          "indication": "-",
          "dosing": {
            "doseOptions": [
              {
                "text": "500 mg/m2 monthly",
                "orderSentence": "Cyclophosphamide 500 mg/m2 IV monthly"
              },
              {
                "text": "1000 mg/m2 monthly",
                "orderSentence": "Cyclophosphamide 1000 mg/m2 IV monthly"
              }
            ],
            "route": "IV",
            "instructions": "750 mg/m2 IV monthly x 6 cycles; pre-hydrate with 1L NS; administer with MESNA (uroprotection)",
            "orderSentence": "Cyclophosphamide 500 mg/m2 IV monthly"
          },
          "contraindications": "Pregnancy; active infection; bone marrow failure; bladder outlet obstruction",
          "monitoring": "CBC weekly x 4 weeks after each cycle (nadir day 10-14); urinalysis; BMP; LFTs; fertility counseling; hemorrhagic cystitis prevention",
          "ED": "-",
          "HOSP": "URGENT",
          "OPD": "ROUTINE",
          "ICU": "URGENT"
        },
        {
          "item": "Tocilizumab (third-line)",
          "route": "IV",
          "indication": "-",
          "dosing": {
            "doseOptions": [
              {
                "text": "4 mg/kg q4wk",
                "orderSentence": "Tocilizumab 4 mg/kg IV q4wk"
              },
              {
                "text": "8 mg/kg q4wk",
                "orderSentence": "Tocilizumab 8 mg/kg IV q4wk"
              }
            ],
            "route": "IV",
            "instructions": "8 mg/kg IV every 4 weeks (max 800 mg/dose)",
            "orderSentence": "Tocilizumab 4 mg/kg IV q4wk"
          },
          "contraindications": "Active infection; hepatic impairment (ALT >5x ULN); diverticulitis; concurrent live vaccines",
          "monitoring": "CBC, LFTs, lipids q4-8 weeks; infection surveillance; GI perforation risk; neutropenia",
          "ED": "-",
          "HOSP": "EXT",
          "OPD": "EXT",
          "ICU": "EXT"
        },
        {
          "item": "Bortezomib (third-line)",
          "route": "IV",
          "indication": "-",
          "dosing": {
            "doseOptions": [
              {
                "text": "1.3 mg/m2",
                "orderSentence": "Bortezomib (third-line) 1.3 mg/m2 IV"
              }
            ],
            "route": "IV",
            "instructions": "1.3 mg/m2 SC/IV on days 1, 4, 8, 11 of 21-day cycles x 4-6 cycles",
            "orderSentence": "Bortezomib (third-line) 1.3 mg/m2 IV"
          },
          "contraindications": "Severe hepatic impairment; peripheral neuropathy grade 2+",
          "monitoring": "CBC; peripheral neuropathy assessment (dose-reduce or hold if worsens); herpes zoster prophylaxis (acyclovir 400 mg BID)",
          "ED": "-",
          "HOSP": "EXT",
          "OPD": "EXT",
          "ICU": "EXT"
        },
        {
          "item": "Repeated IVIG or PLEX cycles",
          "route": "PO",
          "indication": "-",
          "dosing": {
            "doseOptions": [
              {
                "text": "0.4 g/kg",
                "orderSentence": "Repeated IVIG or PLEX cycles 0.4 g/kg PO"
              }
            ],
            "route": "PO",
            "instructions": "IVIG 0.4 g/kg/day x 5 days (repeat q4 weeks) or PLEX 5 exchanges (repeat as needed)",
            "orderSentence": "Repeated IVIG or PLEX cycles 0.4 g/kg PO"
          },
          "contraindications": "Same as first-line",
          "monitoring": "Same as first-line",
          "ED": "-",
          "HOSP": "URGENT",
          "OPD": "ROUTINE",
          "ICU": "URGENT"
        },
        {
          "item": "Oral prednisone taper (following IV methylprednisolone)",
          "route": "IV",
          "indication": "-",
          "dosing": {
            "doseOptions": [
              {
                "text": "1 mg/kg",
                "orderSentence": "Oral prednisone taper (following IV methylprednisolone) 1 mg/kg PO"
              }
            ],
            "route": "PO",
            "instructions": "1 mg/kg/day (max 60 mg) x 2 weeks; taper by 10 mg/week to 20 mg; then taper by 5 mg/week to discontinuation OR low-dose maintenance",
            "orderSentence": "Oral prednisone taper (following IV methylprednisolone) 1 mg/kg PO"
          },
          "contraindications": "Active infection; uncontrolled diabetes; avascular necrosis",
          "monitoring": "Glucose; BP; bone density if prolonged; mood; weight; adrenal insufficiency on taper",
          "ED": "-",
          "HOSP": "ROUTINE",
          "OPD": "ROUTINE",
          "ICU": "-"
        }
      ],
      "Seizure Management": [
        {
          "item": "Levetiracetam (first-line ASM)",
          "route": "IV",
          "indication": "-",
          "dosing": {
            "doseOptions": [
              {
                "text": "250 mg BID",
                "orderSentence": "Levetiracetam 250 mg IV BID"
              },
              {
                "text": "500 mg BID",
                "orderSentence": "Levetiracetam 500 mg IV BID"
              },
              {
                "text": "750 mg BID",
                "orderSentence": "Levetiracetam 750 mg IV BID"
              },
              {
                "text": "1000 mg BID",
                "orderSentence": "Levetiracetam 1000 mg IV BID"
              },
              {
                "text": "1500 mg BID",
                "orderSentence": "Levetiracetam 1500 mg IV BID"
              }
            ],
            "route": "IV",
            "instructions": "Load: 1000-1500 mg IV; Maintenance: 500-1500 mg IV/PO BID (max 3000 mg/day)",
            "orderSentence": "Levetiracetam 250 mg IV BID"
          },
          "pretreatment": "-",
          "contraindications": "Renal impairment (adjust dose per CrCl)",
          "monitoring": "Behavioral changes (rage, irritability); suicidality; renal function",
          "ED": "STAT",
          "HOSP": "STAT",
          "OPD": "ROUTINE",
          "ICU": "STAT"
        },
        {
          "item": "Lacosamide (second-line ASM)",
          "route": "IV",
          "indication": "-",
          "dosing": {
            "doseOptions": [
              {
                "text": "50 mg BID",
                "orderSentence": "Lacosamide 50 mg IV BID"
              },
              {
                "text": "100 mg BID",
                "orderSentence": "Lacosamide 100 mg IV BID"
              },
              {
                "text": "150 mg BID",
                "orderSentence": "Lacosamide 150 mg IV BID"
              },
              {
                "text": "200 mg BID",
                "orderSentence": "Lacosamide 200 mg IV BID"
              }
            ],
            "route": "IV",
            "instructions": "Load: 200-400 mg IV; Maintenance: 100-200 mg IV/PO BID (max 400 mg/day)",
            "orderSentence": "Lacosamide 50 mg IV BID"
          },
          "pretreatment": "-",
          "contraindications": "Second/third degree AV block; severe hepatic impairment",
          "monitoring": "ECG (PR prolongation); dizziness; cardiac monitoring during load",
          "ED": "URGENT",
          "HOSP": "URGENT",
          "OPD": "ROUTINE",
          "ICU": "URGENT"
        },
        {
          "item": "Valproic acid",
          "route": "IV",
          "indication": "-",
          "dosing": {
            "doseOptions": [
              {
                "text": "250 mg BID",
                "orderSentence": "Valproic Acid 250 mg IV BID"
              },
              {
                "text": "500 mg BID",
                "orderSentence": "Valproic Acid 500 mg IV BID"
              },
              {
                "text": "750 mg BID",
                "orderSentence": "Valproic Acid 750 mg IV BID"
              },
              {
                "text": "1000 mg BID",
                "orderSentence": "Valproic Acid 1000 mg IV BID"
              }
            ],
            "route": "IV",
            "instructions": "Load: 20-40 mg/kg IV (max rate 6 mg/kg/min); Maintenance: 250-500 mg IV/PO q8h (target level 50-100 mcg/mL)",
            "orderSentence": "Valproic Acid 250 mg IV BID"
          },
          "pretreatment": "-",
          "contraindications": "Pregnancy (teratogenic -- Category X); hepatic disease; urea cycle disorders; mitochondrial disease (POLG)",
          "monitoring": "LFTs; ammonia; CBC (thrombocytopenia); drug level; pancreatitis",
          "ED": "URGENT",
          "HOSP": "URGENT",
          "OPD": "ROUTINE",
          "ICU": "URGENT"
        },
        {
          "item": "Brivaracetam",
          "route": "IV",
          "indication": "-",
          "dosing": {
            "doseOptions": [
              {
                "text": "25 mg BID",
                "orderSentence": "Brivaracetam 25 mg IV BID"
              },
              {
                "text": "50 mg BID",
                "orderSentence": "Brivaracetam 50 mg IV BID"
              },
              {
                "text": "75 mg BID",
                "orderSentence": "Brivaracetam 75 mg IV BID"
              },
              {
                "text": "100 mg BID",
                "orderSentence": "Brivaracetam 100 mg IV BID"
              }
            ],
            "route": "IV",
            "instructions": "Load: 100 mg IV; Maintenance: 50-100 mg IV/PO BID (max 200 mg/day)",
            "orderSentence": "Brivaracetam 25 mg IV BID"
          },
          "pretreatment": "-",
          "contraindications": "Hepatic impairment (reduce dose)",
          "monitoring": "Behavioral changes; sedation",
          "ED": "-",
          "HOSP": "URGENT",
          "OPD": "ROUTINE",
          "ICU": "URGENT"
        },
        {
          "item": "Clobazam",
          "route": "PO",
          "indication": "-",
          "dosing": {
            "doseOptions": [
              {
                "text": "5 mg BID",
                "orderSentence": "Clobazam 5 mg PO BID"
              },
              {
                "text": "10 mg BID",
                "orderSentence": "Clobazam 10 mg PO BID"
              },
              {
                "text": "20 mg BID",
                "orderSentence": "Clobazam 20 mg PO BID"
              }
            ],
            "route": "PO",
            "instructions": "Start 5-10 mg BID; titrate to 20-40 mg/day in divided doses",
            "orderSentence": "Clobazam 5 mg PO BID"
          },
          "pretreatment": "-",
          "contraindications": "Severe hepatic impairment; myasthenia gravis",
          "monitoring": "Sedation; CYP2C19 poor metabolizers (reduce dose); tolerance; dependence",
          "ED": "-",
          "HOSP": "ROUTINE",
          "OPD": "ROUTINE",
          "ICU": "ROUTINE"
        },
        {
          "item": "Phenytoin/fosphenytoin (refractory)",
          "route": "IV",
          "indication": "-",
          "dosing": {
            "doseOptions": [
              {
                "text": "20 mg",
                "orderSentence": "Phenytoin/fosphenytoin (refractory) 20 mg IV"
              }
            ],
            "route": "IV",
            "instructions": "Fosphenytoin: 20 mg PE/kg IV (max rate 150 mg PE/min); Maintenance: 5-7 mg/kg/day divided BID-TID (target level 10-20 mcg/mL)",
            "orderSentence": "Phenytoin/fosphenytoin (refractory) 20 mg IV"
          },
          "pretreatment": "-",
          "contraindications": "AV block; bradycardia",
          "monitoring": "Continuous cardiac monitoring during load; drug level; purple glove syndrome (peripheral IV); gingival hyperplasia",
          "ED": "STAT",
          "HOSP": "STAT",
          "OPD": "-",
          "ICU": "STAT"
        },
        {
          "item": "Phenobarbital (refractory)",
          "route": "IV",
          "indication": "-",
          "dosing": {
            "doseOptions": [
              {
                "text": "15-20 mg/kg",
                "orderSentence": "Phenobarbital (refractory) 15-20 mg/kg IV"
              }
            ],
            "route": "IV",
            "instructions": "Load: 15-20 mg/kg IV (max rate 60 mg/min); Maintenance: 1-3 mg/kg/day (target level 15-40 mcg/mL)",
            "orderSentence": "Phenobarbital (refractory) 15-20 mg/kg IV"
          },
          "pretreatment": "-",
          "contraindications": "Severe respiratory depression; porphyria",
          "monitoring": "Respiratory depression; sedation; hypotension; drug level",
          "ED": "-",
          "HOSP": "URGENT",
          "OPD": "-",
          "ICU": "URGENT"
        },
        {
          "item": "Midazolam infusion (refractory SE)",
          "route": "IV",
          "indication": "-",
          "dosing": {
            "doseOptions": [
              {
                "text": "2 mg once",
                "orderSentence": "Midazolam 2 mg IV once"
              },
              {
                "text": "5 mg once",
                "orderSentence": "Midazolam 5 mg IV once"
              },
              {
                "text": "10 mg once",
                "orderSentence": "Midazolam 10 mg IV once"
              }
            ],
            "route": "IV",
            "instructions": "Bolus: 0.2 mg/kg IV; Infusion: 0.1-2.0 mg/kg/hr; titrate to EEG burst suppression",
            "orderSentence": "Midazolam 2 mg IV once"
          },
          "pretreatment": "-",
          "contraindications": "Unprotected airway (requires intubation)",
          "monitoring": "Continuous EEG; respiratory status; hemodynamics; tachyphylaxis",
          "ED": "-",
          "HOSP": "-",
          "OPD": "-",
          "ICU": "STAT"
        },
        {
          "item": "Propofol infusion (refractory SE)",
          "route": "IV",
          "indication": "-",
          "dosing": {
            "doseOptions": [
              {
                "text": "1-2 mg/kg",
                "orderSentence": "Propofol infusion (refractory SE) 1-2 mg/kg IV"
              }
            ],
            "route": "IV",
            "instructions": "Bolus: 1-2 mg/kg IV; Infusion: 20-80 mcg/kg/min (max 5 mg/kg/hr to avoid PRIS)",
            "orderSentence": "Propofol infusion (refractory SE) 1-2 mg/kg IV"
          },
          "pretreatment": "-",
          "contraindications": "Propofol infusion syndrome risk (prolonged use >48h at high doses); egg/soy allergy",
          "monitoring": "Continuous EEG; triglycerides q48h; CPK; lactate; hemodynamics; PRIS surveillance",
          "ED": "-",
          "HOSP": "-",
          "OPD": "-",
          "ICU": "STAT"
        },
        {
          "item": "Ketamine infusion (super-refractory SE)",
          "route": "IV",
          "indication": "-",
          "dosing": {
            "doseOptions": [
              {
                "text": "1-3 mg/kg",
                "orderSentence": "Ketamine infusion (super-refractory SE) 1-3 mg/kg IV"
              }
            ],
            "route": "IV",
            "instructions": "Bolus: 1-3 mg/kg IV; Infusion: 0.5-5 mg/kg/hr",
            "orderSentence": "Ketamine infusion (super-refractory SE) 1-3 mg/kg IV"
          },
          "pretreatment": "-",
          "contraindications": "Uncontrolled hypertension; raised ICP (relative)",
          "monitoring": "Continuous EEG; BP; HR; hepatic function; laryngospasm risk",
          "ED": "-",
          "HOSP": "-",
          "OPD": "-",
          "ICU": "STAT"
        }
      ],
      "Psychiatric Symptom Management": [
        {
          "item": "Haloperidol (acute agitation)",
          "route": "IV",
          "indication": "-",
          "dosing": {
            "doseOptions": [
              {
                "text": "0.5 mg BID",
                "orderSentence": "Haloperidol 0.5 mg IV BID"
              },
              {
                "text": "1 mg BID",
                "orderSentence": "Haloperidol 1 mg IV BID"
              },
              {
                "text": "2 mg BID",
                "orderSentence": "Haloperidol 2 mg IV BID"
              },
              {
                "text": "5 mg q4h PRN",
                "orderSentence": "Haloperidol 5 mg IV q4h PRN"
              }
            ],
            "route": "IV",
            "instructions": "0.5-2 mg IV/IM q4-6h PRN (lowest effective dose); max 20 mg/day",
            "orderSentence": "Haloperidol 0.5 mg IV BID"
          },
          "contraindications": "QTc >500 ms; Parkinson disease; prior NMS",
          "monitoring": "ECG (QTc); EPS; NMS surveillance; temperature; CPK if NMS suspected",
          "ED": "STAT",
          "HOSP": "STAT",
          "OPD": "-",
          "ICU": "STAT"
        },
        {
          "item": "Olanzapine (agitation/psychosis)",
          "route": "IM",
          "indication": "-",
          "dosing": {
            "doseOptions": [
              {
                "text": "2.5 mg daily",
                "orderSentence": "Olanzapine 2.5 mg IM daily"
              },
              {
                "text": "5 mg daily",
                "orderSentence": "Olanzapine 5 mg IM daily"
              },
              {
                "text": "10 mg daily",
                "orderSentence": "Olanzapine 10 mg IM daily"
              }
            ],
            "route": "IM",
            "instructions": "2.5-5 mg PO/IM BID (start low); max 20 mg/day",
            "orderSentence": "Olanzapine 2.5 mg IM daily"
          },
          "contraindications": "QTc prolongation; metabolic syndrome",
          "monitoring": "Glucose; lipids; QTc; weight; sedation; EPS",
          "ED": "-",
          "HOSP": "ROUTINE",
          "OPD": "ROUTINE",
          "ICU": "ROUTINE"
        },
        {
          "item": "Quetiapine (psychosis/insomnia)",
          "route": "PO",
          "indication": "-",
          "dosing": {
            "doseOptions": [
              {
                "text": "12.5 mg QHS",
                "orderSentence": "Quetiapine 12.5 mg PO QHS"
              },
              {
                "text": "25 mg QHS",
                "orderSentence": "Quetiapine 25 mg PO QHS"
              },
              {
                "text": "50 mg QHS",
                "orderSentence": "Quetiapine 50 mg PO QHS"
              },
              {
                "text": "100 mg QHS",
                "orderSentence": "Quetiapine 100 mg PO QHS"
              }
            ],
            "route": "PO",
            "instructions": "Start 25-50 mg qHS; titrate to 200-400 mg/day in divided doses",
            "orderSentence": "Quetiapine 12.5 mg PO QHS"
          },
          "contraindications": "QTc prolongation; severe hepatic impairment",
          "monitoring": "QTc; metabolic parameters; orthostatic BP; sedation",
          "ED": "-",
          "HOSP": "ROUTINE",
          "OPD": "ROUTINE",
          "ICU": "-"
        },
        {
          "item": "Lorazepam (catatonia -- first-line)",
          "route": "IV",
          "indication": "-",
          "dosing": {
            "doseOptions": [
              {
                "text": "0.5 mg TID",
                "orderSentence": "Lorazepam 0.5 mg IV TID"
              },
              {
                "text": "1 mg TID",
                "orderSentence": "Lorazepam 1 mg IV TID"
              },
              {
                "text": "2 mg TID",
                "orderSentence": "Lorazepam 2 mg IV TID"
              }
            ],
            "route": "IV",
            "instructions": "Start 1-2 mg IV/PO; if response, 1-2 mg q4-8h (escalate to 8-24 mg/day as needed for catatonia)",
            "orderSentence": "Lorazepam 0.5 mg IV TID"
          },
          "contraindications": "Respiratory compromise (high doses)",
          "monitoring": "Bush-Francis Catatonia Rating Scale; respiratory rate; sedation; airway",
          "ED": "STAT",
          "HOSP": "STAT",
          "OPD": "ROUTINE",
          "ICU": "STAT"
        },
        {
          "item": "Dexmedetomidine (agitation in ICU)",
          "route": "IV",
          "indication": "-",
          "dosing": {
            "doseOptions": [
              {
                "text": "1 mcg/kg",
                "orderSentence": "Dexmedetomidine (agitation in ICU) 1 mcg/kg IV"
              }
            ],
            "route": "IV",
            "instructions": "Load: 1 mcg/kg IV over 10 min (optional); Infusion: 0.2-0.7 mcg/kg/hr (max 1.5 mcg/kg/hr)",
            "orderSentence": "Dexmedetomidine (agitation in ICU) 1 mcg/kg IV"
          },
          "contraindications": "Severe bradycardia; advanced heart block",
          "monitoring": "HR (bradycardia); BP (hypotension); sedation level (RASS)",
          "ED": "-",
          "HOSP": "-",
          "OPD": "-",
          "ICU": "STAT"
        },
        {
          "item": "Valproic acid (mood stabilization/agitation)",
          "route": "PO",
          "indication": "-",
          "dosing": {
            "doseOptions": [
              {
                "text": "250 mg BID",
                "orderSentence": "Valproic Acid 250 mg PO BID"
              },
              {
                "text": "500 mg BID",
                "orderSentence": "Valproic Acid 500 mg PO BID"
              },
              {
                "text": "750 mg BID",
                "orderSentence": "Valproic Acid 750 mg PO BID"
              },
              {
                "text": "1000 mg BID",
                "orderSentence": "Valproic Acid 1000 mg PO BID"
              }
            ],
            "route": "PO",
            "instructions": "250-500 mg PO BID; titrate to level 50-100 mcg/mL (dual benefit: mood + seizure)",
            "orderSentence": "Valproic Acid 250 mg PO BID"
          },
          "contraindications": "Pregnancy; hepatic disease",
          "monitoring": "LFTs; ammonia; CBC; drug level",
          "ED": "-",
          "HOSP": "ROUTINE",
          "OPD": "ROUTINE",
          "ICU": "ROUTINE"
        },
        {
          "item": "Melatonin (sleep-wake disturbance)",
          "route": "PO",
          "indication": "-",
          "dosing": {
            "doseOptions": [
              {
                "text": "1 mg QHS",
                "orderSentence": "Melatonin 1 mg PO QHS"
              },
              {
                "text": "3 mg QHS",
                "orderSentence": "Melatonin 3 mg PO QHS"
              },
              {
                "text": "5 mg QHS",
                "orderSentence": "Melatonin 5 mg PO QHS"
              },
              {
                "text": "10 mg QHS",
                "orderSentence": "Melatonin 10 mg PO QHS"
              }
            ],
            "route": "PO",
            "instructions": "3-10 mg PO qHS",
            "orderSentence": "Melatonin 1 mg PO QHS"
          },
          "contraindications": "None significant",
          "monitoring": "Sleep quality; no significant drug interactions",
          "ED": "-",
          "HOSP": "ROUTINE",
          "OPD": "ROUTINE",
          "ICU": "ROUTINE"
        },
        {
          "item": "Trazodone (insomnia)",
          "route": "PO",
          "indication": "-",
          "dosing": {
            "doseOptions": [
              {
                "text": "25 mg QHS",
                "orderSentence": "Trazodone 25 mg PO QHS"
              },
              {
                "text": "50 mg QHS",
                "orderSentence": "Trazodone 50 mg PO QHS"
              },
              {
                "text": "100 mg QHS",
                "orderSentence": "Trazodone 100 mg PO QHS"
              },
              {
                "text": "150 mg QHS",
                "orderSentence": "Trazodone 150 mg PO QHS"
              }
            ],
            "route": "PO",
            "instructions": "25-100 mg PO qHS",
            "orderSentence": "Trazodone 25 mg PO QHS"
          },
          "contraindications": "Concurrent MAOIs; QTc prolongation",
          "monitoring": "Orthostatic hypotension; priapism (rare); sedation",
          "ED": "-",
          "HOSP": "ROUTINE",
          "OPD": "ROUTINE",
          "ICU": "-"
        },
        {
          "item": "Electroconvulsive therapy (ECT) (refractory catatonia)",
          "route": "-",
          "indication": "-",
          "dosing": {
            "doseOptions": [
              {
                "text": "N/A",
                "orderSentence": "Electroconvulsive therapy (ECT) (refractory catatonia) N/A -"
              }
            ],
            "route": "-",
            "instructions": "Per psychiatry protocol; typically 3x/week",
            "orderSentence": "Electroconvulsive therapy (ECT) (refractory catatonia) N/A -"
          },
          "contraindications": "Pheochromocytoma; raised ICP (relative)",
          "monitoring": "Anesthesia monitoring; cognitive function; post-procedure seizure threshold",
          "ED": "-",
          "HOSP": "EXT",
          "OPD": "EXT",
          "ICU": "EXT"
        }
      ],
      "ICU-Specific Treatments": [
        {
          "item": "Intubation and mechanical ventilation",
          "route": "-",
          "indication": "-",
          "dosing": {
            "doseOptions": [
              {
                "text": "N/A",
                "orderSentence": "Intubation and mechanical ventilation N/A -"
              }
            ],
            "route": "-",
            "instructions": "RSI: avoid succinylcholine if hyperkalemia risk; maintain normocapnia",
            "orderSentence": "Intubation and mechanical ventilation N/A -"
          },
          "contraindications": "As per standard airway management",
          "monitoring": "Ventilator parameters; ABG; daily SBT when appropriate",
          "ED": "-",
          "HOSP": "-",
          "OPD": "-",
          "ICU": "STAT"
        },
        {
          "item": "Labetalol IV (autonomic hypertensive crisis)",
          "route": "IV",
          "indication": "-",
          "dosing": {
            "doseOptions": [
              {
                "text": "100 mg BID",
                "orderSentence": "Labetalol 100 mg IV BID"
              },
              {
                "text": "200 mg BID",
                "orderSentence": "Labetalol 200 mg IV BID"
              },
              {
                "text": "300 mg BID",
                "orderSentence": "Labetalol 300 mg IV BID"
              },
              {
                "text": "10 mg q10min PRN",
                "orderSentence": "Labetalol 10 mg IV q10min PRN"
              },
              {
                "text": "20 mg q10min PRN",
                "orderSentence": "Labetalol 20 mg IV q10min PRN"
              }
            ],
            "route": "IV",
            "instructions": "10-20 mg IV q10-15min PRN; or infusion 0.5-2 mg/min; target SBP <180",
            "orderSentence": "Labetalol 100 mg IV BID"
          },
          "contraindications": "Severe bradycardia; AV block; decompensated CHF; asthma",
          "monitoring": "Continuous BP; HR; I/O",
          "ED": "-",
          "HOSP": "-",
          "OPD": "-",
          "ICU": "STAT"
        },
        {
          "item": "Esmolol IV (autonomic tachycardia)",
          "route": "IV",
          "indication": "-",
          "dosing": {
            "doseOptions": [
              {
                "text": "500 mcg/kg",
                "orderSentence": "Esmolol IV (autonomic tachycardia) 500 mcg/kg IV"
              }
            ],
            "route": "IV",
            "instructions": "Bolus: 500 mcg/kg over 1 min; Infusion: 50-200 mcg/kg/min",
            "orderSentence": "Esmolol IV (autonomic tachycardia) 500 mcg/kg IV"
          },
          "contraindications": "Severe bradycardia; decompensated CHF; cardiogenic shock",
          "monitoring": "Continuous HR/BP; ECG",
          "ED": "-",
          "HOSP": "-",
          "OPD": "-",
          "ICU": "STAT"
        },
        {
          "item": "Atropine (autonomic bradycardia)",
          "route": "IV",
          "indication": "-",
          "dosing": {
            "doseOptions": [
              {
                "text": "0.5-1 mg",
                "orderSentence": "Atropine (autonomic bradycardia) 0.5-1 mg IV"
              }
            ],
            "route": "IV",
            "instructions": "0.5-1 mg IV q3-5min (max 3 mg total)",
            "orderSentence": "Atropine (autonomic bradycardia) 0.5-1 mg IV"
          },
          "contraindications": "Tachycardia; thyrotoxicosis",
          "monitoring": "HR; rhythm",
          "ED": "-",
          "HOSP": "-",
          "OPD": "-",
          "ICU": "STAT"
        },
        {
          "item": "Isoproterenol drip (severe autonomic bradycardia)",
          "route": "IV",
          "indication": "-",
          "dosing": {
            "doseOptions": [
              {
                "text": "2-10 mcg",
                "orderSentence": "Isoproterenol drip (severe autonomic bradycardia) 2-10 mcg IV"
              }
            ],
            "route": "IV",
            "instructions": "2-10 mcg/min IV infusion; titrate to HR >60",
            "orderSentence": "Isoproterenol drip (severe autonomic bradycardia) 2-10 mcg IV"
          },
          "contraindications": "Tachyarrhythmia; digoxin toxicity",
          "monitoring": "Continuous ECG; HR; BP",
          "ED": "-",
          "HOSP": "-",
          "OPD": "-",
          "ICU": "STAT"
        },
        {
          "item": "Temporary transvenous pacemaker",
          "route": "-",
          "indication": "-",
          "dosing": {
            "doseOptions": [
              {
                "text": "N/A",
                "orderSentence": "Temporary transvenous pacemaker N/A -"
              }
            ],
            "route": "-",
            "instructions": "Per cardiology if pharmacologic measures fail",
            "orderSentence": "Temporary transvenous pacemaker N/A -"
          },
          "contraindications": "Active infection at insertion site",
          "monitoring": "Capture; sensing; threshold checks",
          "ED": "-",
          "HOSP": "-",
          "OPD": "-",
          "ICU": "STAT"
        },
        {
          "item": "Norepinephrine (autonomic hypotension)",
          "route": "IV",
          "indication": "-",
          "dosing": {
            "doseOptions": [
              {
                "text": "0.1-0.5 mcg/kg",
                "orderSentence": "Norepinephrine (autonomic hypotension) 0.1-0.5 mcg/kg IV"
              }
            ],
            "route": "IV",
            "instructions": "0.1-0.5 mcg/kg/min IV; titrate to MAP >65",
            "orderSentence": "Norepinephrine (autonomic hypotension) 0.1-0.5 mcg/kg IV"
          },
          "contraindications": "Peripheral ischemia risk at high doses",
          "monitoring": "Arterial line; MAP; lactate; urine output",
          "ED": "-",
          "HOSP": "-",
          "OPD": "-",
          "ICU": "STAT"
        },
        {
          "item": "DVT prophylaxis (enoxaparin)",
          "route": "SC",
          "indication": "-",
          "dosing": {
            "doseOptions": [
              {
                "text": "40 mg",
                "orderSentence": "DVT prophylaxis (enoxaparin) 40 mg SC"
              }
            ],
            "route": "SC",
            "instructions": "40 mg SC daily (adjust for renal function: 30 mg SC daily if CrCl <30)",
            "orderSentence": "DVT prophylaxis (enoxaparin) 40 mg SC"
          },
          "contraindications": "Active bleeding; HIT; severe thrombocytopenia",
          "monitoring": "Platelet count; anti-Xa if renal impairment; bleeding signs",
          "ED": "-",
          "HOSP": "STAT",
          "OPD": "-",
          "ICU": "STAT"
        },
        {
          "item": "Temperature management (hyperthermia)",
          "route": "IV",
          "indication": "-",
          "dosing": {
            "doseOptions": [
              {
                "text": "1g",
                "orderSentence": "Temperature management (hyperthermia) 1g IV"
              }
            ],
            "route": "IV",
            "instructions": "Targeted temperature: 36-37C; cooling blankets; acetaminophen 1g IV/PO q6h PRN",
            "orderSentence": "Temperature management (hyperthermia) 1g IV"
          },
          "contraindications": "Avoid overcooling; avoid shivering (increases metabolic demand)",
          "monitoring": "Continuous temperature; shivering assessment (BSAS)",
          "ED": "-",
          "HOSP": "-",
          "OPD": "-",
          "ICU": "STAT"
        },
        {
          "item": "Sodium correction (hyponatremia -- LGI1)",
          "route": "IV",
          "indication": "-",
          "dosing": {
            "doseOptions": [
              {
                "text": "100-150 mL",
                "orderSentence": "Sodium correction (hyponatremia -- LGI1) 100-150 mL IV"
              }
            ],
            "route": "IV",
            "instructions": "If Na <125: 3% NaCl 100-150 mL IV over 10-20 min (repeat up to 3x); Target correction: 4-6 mEq/L in first 6h, max 8 mEq/L in 24h",
            "orderSentence": "Sodium correction (hyponatremia -- LGI1) 100-150 mL IV"
          },
          "contraindications": "Avoid overcorrection (osmotic demyelination risk)",
          "monitoring": "Sodium q2-4h during correction; urine output; neurologic status",
          "ED": "URGENT",
          "HOSP": "URGENT",
          "OPD": "ROUTINE",
          "ICU": "URGENT"
        },
        {
          "item": "Fludrocortisone (chronic hyponatremia -- LGI1)",
          "route": "PO",
          "indication": "-",
          "dosing": {
            "doseOptions": [
              {
                "text": "0.1 mg daily",
                "orderSentence": "Fludrocortisone 0.1 mg PO daily"
              },
              {
                "text": "0.2 mg daily",
                "orderSentence": "Fludrocortisone 0.2 mg PO daily"
              },
              {
                "text": "0.3 mg daily",
                "orderSentence": "Fludrocortisone 0.3 mg PO daily"
              }
            ],
            "route": "PO",
            "instructions": "0.05-0.2 mg PO daily",
            "orderSentence": "Fludrocortisone 0.1 mg PO daily"
          },
          "contraindications": "CHF; hypertension",
          "monitoring": "Sodium; potassium; BP; edema",
          "ED": "-",
          "HOSP": "ROUTINE",
          "OPD": "ROUTINE",
          "ICU": "-"
        },
        {
          "item": "Fluid restriction (SIADH-related hyponatremia)",
          "route": "-",
          "indication": "-",
          "dosing": {
            "doseOptions": [
              {
                "text": "N/A",
                "orderSentence": "Fluid restriction (SIADH-related hyponatremia) N/A -"
              }
            ],
            "route": "-",
            "instructions": "Restrict to 1-1.2 L/day if SIADH suspected (LGI1)",
            "orderSentence": "Fluid restriction (SIADH-related hyponatremia) N/A -"
          },
          "contraindications": "Dehydration risk",
          "monitoring": "Sodium; I/O; daily weight; urine osmolality",
          "ED": "-",
          "HOSP": "ROUTINE",
          "OPD": "-",
          "ICU": "ROUTINE"
        }
      ],
      "Long-Term Immunosuppression / Maintenance": [
        {
          "item": "Mycophenolate mofetil (CellCept)",
          "route": "PO",
          "indication": "-",
          "dosing": {
            "doseOptions": [
              {
                "text": "500 mg BID",
                "orderSentence": "Mycophenolate Mofetil 500 mg PO BID"
              },
              {
                "text": "1000 mg BID",
                "orderSentence": "Mycophenolate Mofetil 1000 mg PO BID"
              },
              {
                "text": "1500 mg BID",
                "orderSentence": "Mycophenolate Mofetil 1500 mg PO BID"
              }
            ],
            "route": "PO",
            "instructions": "Start 500 mg PO BID; increase to 1000 mg PO BID over 2-4 weeks (target 1500-3000 mg/day)",
            "orderSentence": "Mycophenolate Mofetil 500 mg PO BID"
          },
          "contraindications": "Pregnancy (Category D -- teratogenic); active infection",
          "monitoring": "CBC q2 weeks x 3 months, then monthly; LFTs; GI symptoms; infection surveillance; pregnancy prevention",
          "ED": "-",
          "HOSP": "-",
          "OPD": "ROUTINE",
          "ICU": "-"
        },
        {
          "item": "Azathioprine (Imuran)",
          "route": "PO",
          "indication": "-",
          "dosing": {
            "doseOptions": [
              {
                "text": "50 mg daily",
                "orderSentence": "Azathioprine 50 mg PO daily"
              },
              {
                "text": "100 mg daily",
                "orderSentence": "Azathioprine 100 mg PO daily"
              },
              {
                "text": "150 mg daily",
                "orderSentence": "Azathioprine 150 mg PO daily"
              },
              {
                "text": "2-3 mg/kg daily",
                "orderSentence": "Azathioprine 2-3 mg/kg PO daily"
              }
            ],
            "route": "PO",
            "instructions": "Start 50 mg PO daily; increase by 50 mg every 2 weeks to target 2-3 mg/kg/day",
            "orderSentence": "Azathioprine 50 mg PO daily"
          },
          "contraindications": "TPMT deficiency (check before starting); pregnancy (relative)",
          "monitoring": "TPMT genotype/activity before starting; CBC q2 weeks x 2 months, then monthly; LFTs; pancreatitis",
          "ED": "-",
          "HOSP": "-",
          "OPD": "ROUTINE",
          "ICU": "-"
        },
        {
          "item": "Rituximab (maintenance)",
          "route": "IV",
          "indication": "-",
          "dosing": {
            "doseOptions": [
              {
                "text": "375 mg/m2 weekly x4",
                "orderSentence": "Rituximab 375 mg/m2 IV weekly x4"
              },
              {
                "text": "500 mg q6mo",
                "orderSentence": "Rituximab 500 mg IV q6mo"
              },
              {
                "text": "1000 mg q6mo",
                "orderSentence": "Rituximab 1000 mg IV q6mo"
              }
            ],
            "route": "IV",
            "instructions": "500-1000 mg IV every 6 months; re-dose based on CD19/CD20 B-cell repopulation or clinical relapse",
            "orderSentence": "Rituximab 375 mg/m2 IV weekly x4"
          },
          "contraindications": "Active hepatitis B; severe active infection",
          "monitoring": "CD19/CD20 counts q3 months; immunoglobulin levels q3-6 months; hepatitis B surveillance; infection monitoring; PML surveillance",
          "ED": "-",
          "HOSP": "-",
          "OPD": "ROUTINE",
          "ICU": "-"
        },
        {
          "item": "Oral prednisone (low-dose maintenance)",
          "route": "PO",
          "indication": "-",
          "dosing": {
            "doseOptions": [
              {
                "text": "5-10 mg",
                "orderSentence": "Oral prednisone (low-dose maintenance) 5-10 mg PO"
              }
            ],
            "route": "PO",
            "instructions": "5-10 mg PO daily; aim to taper off within 3-6 months if on steroid-sparing agent",
            "orderSentence": "Oral prednisone (low-dose maintenance) 5-10 mg PO"
          },
          "contraindications": "Poorly controlled diabetes; active infection; avascular necrosis",
          "monitoring": "Glucose; BP; bone density (DEXA if >3 months); weight; mood; cataracts; adrenal assessment on taper",
          "ED": "-",
          "HOSP": "-",
          "OPD": "ROUTINE",
          "ICU": "-"
        },
        {
          "item": "IVIG (maintenance)",
          "route": "IV",
          "indication": "-",
          "dosing": {
            "doseOptions": [
              {
                "text": "0.4 g/kg daily x5 days",
                "orderSentence": "Ivig 0.4 g/kg IV daily x5 days"
              },
              {
                "text": "1 g/kg daily x2 days",
                "orderSentence": "Ivig 1 g/kg IV daily x2 days"
              },
              {
                "text": "2 g/kg divided over 2-5 days",
                "orderSentence": "Ivig 2 g/kg IV divided over 2-5 days"
              }
            ],
            "route": "IV",
            "instructions": "0.4 g/kg IV every 4 weeks OR 1-2 g/kg IV every 4-6 weeks (adjust per response)",
            "orderSentence": "Ivig 0.4 g/kg IV daily x5 days"
          },
          "contraindications": "IgA deficiency; thromboembolic history",
          "monitoring": "Renal function; headache; IgG trough levels; infusion reactions",
          "ED": "-",
          "HOSP": "-",
          "OPD": "ROUTINE",
          "ICU": "-"
        },
        {
          "item": "Calcium + Vitamin D (bone protection with steroids)",
          "route": "-",
          "indication": "-",
          "dosing": {
            "doseOptions": [
              {
                "text": "500 mg Ca + 400 IU D daily",
                "orderSentence": "Calcium + Vitamin D 500 mg Ca + 400 IU D PO daily"
              },
              {
                "text": "500 mg Ca + 1000 IU D BID",
                "orderSentence": "Calcium + Vitamin D 500 mg Ca + 1000 IU D PO BID"
              },
              {
                "text": "1000 mg Ca + 2000 IU D daily",
                "orderSentence": "Calcium + Vitamin D 1000 mg Ca + 2000 IU D PO daily"
              }
            ],
            "route": "PO",
            "instructions": "Calcium 1000-1200 mg/day + Vitamin D 1000-2000 IU/day",
            "orderSentence": "Calcium + Vitamin D 500 mg Ca + 400 IU D PO daily"
          },
          "contraindications": "Hypercalcemia; kidney stones",
          "monitoring": "25-OH Vitamin D level; calcium; DEXA baseline if anticipated steroid use >3 months",
          "ED": "-",
          "HOSP": "ROUTINE",
          "OPD": "ROUTINE",
          "ICU": "-"
        }
      ]
    },
    "Other Recommendations": {
      "Referrals & Consults": [
        {
          "item": "Neurology (autoimmune/neuroimmunology)",
          "ED": "STAT",
          "HOSP": "STAT",
          "OPD": "ROUTINE",
          "ICU": "STAT",
          "indication": "All suspected autoimmune encephalitis cases; immunotherapy management"
        },
        {
          "item": "Epilepsy/EEG service",
          "ED": "STAT",
          "HOSP": "STAT",
          "OPD": "ROUTINE",
          "ICU": "STAT",
          "indication": "Seizure management; continuous EEG monitoring; extreme delta brush interpretation"
        },
        {
          "item": "Psychiatry",
          "ED": "URGENT",
          "HOSP": "URGENT",
          "OPD": "ROUTINE",
          "ICU": "URGENT",
          "indication": "Psychiatric manifestations (psychosis, catatonia, agitation); antipsychotic management; NMS risk"
        },
        {
          "item": "Critical care/ICU",
          "ED": "URGENT",
          "HOSP": "URGENT",
          "OPD": "-",
          "ICU": "-",
          "indication": "Autonomic instability; respiratory failure; refractory status epilepticus; altered consciousness"
        },
        {
          "item": "Gynecologic oncology (females with anti-NMDAR)",
          "ED": "-",
          "HOSP": "URGENT",
          "OPD": "URGENT",
          "ICU": "URGENT",
          "indication": "Ovarian teratoma screening and surgical resection"
        },
        {
          "item": "Oncology",
          "ED": "-",
          "HOSP": "URGENT",
          "OPD": "ROUTINE",
          "ICU": "URGENT",
          "indication": "Any identified malignancy; tumor screening guidance; chemotherapy planning"
        },
        {
          "item": "Urology (males <50 with anti-Ma2/KLHL11)",
          "ED": "-",
          "HOSP": "URGENT",
          "OPD": "ROUTINE",
          "ICU": "-",
          "indication": "Testicular germ cell tumor screening"
        },
        {
          "item": "Hematology/apheresis",
          "ED": "-",
          "HOSP": "URGENT",
          "OPD": "-",
          "ICU": "URGENT",
          "indication": "PLEX coordination; catheter placement"
        },
        {
          "item": "Physical therapy",
          "ED": "-",
          "HOSP": "ROUTINE",
          "OPD": "ROUTINE",
          "ICU": "ROUTINE",
          "indication": "Motor rehabilitation; gait training; fall prevention"
        },
        {
          "item": "Occupational therapy",
          "ED": "-",
          "HOSP": "ROUTINE",
          "OPD": "ROUTINE",
          "ICU": "ROUTINE",
          "indication": "ADL assessment; cognitive rehabilitation; adaptive strategies"
        },
        {
          "item": "Speech-language pathology",
          "ED": "-",
          "HOSP": "ROUTINE",
          "OPD": "ROUTINE",
          "ICU": "ROUTINE",
          "indication": "Swallowing evaluation; language/communication rehabilitation; cognitive-linguistic therapy"
        },
        {
          "item": "Neuropsychology",
          "ED": "-",
          "HOSP": "-",
          "OPD": "ROUTINE",
          "ICU": "-",
          "indication": "Formal cognitive assessment; rehabilitation planning; serial monitoring"
        },
        {
          "item": "Social work",
          "ED": "-",
          "HOSP": "ROUTINE",
          "OPD": "ROUTINE",
          "ICU": "-",
          "indication": "Family support; insurance navigation; disability resources; long-term care planning"
        },
        {
          "item": "Rehabilitation medicine",
          "ED": "-",
          "HOSP": "ROUTINE",
          "OPD": "ROUTINE",
          "ICU": "-",
          "indication": "Comprehensive inpatient or outpatient rehab program coordination"
        },
        {
          "item": "Palliative care",
          "ED": "-",
          "HOSP": "EXT",
          "OPD": "EXT",
          "ICU": "EXT",
          "indication": "Refractory cases; prolonged ICU stay; family support; goals of care discussion"
        },
        {
          "item": "Infectious disease",
          "ED": "URGENT",
          "HOSP": "URGENT",
          "OPD": "-",
          "ICU": "URGENT",
          "indication": "Rule out infection; antimicrobial guidance; post-immunosuppression infection management"
        },
        {
          "item": "Endocrinology",
          "ED": "-",
          "HOSP": "ROUTINE",
          "OPD": "ROUTINE",
          "ICU": "-",
          "indication": "Steroid-induced hyperglycemia management; thyroid evaluation if Hashimoto suspected"
        }
      ],
      "Patient/Family Instructions": [
        {
          "item": "Return to ED immediately for new seizures, sudden behavioral changes, fever, difficulty breathing, or loss of consciousness",
          "ED": "Y",
          "HOSP": "Y",
          "OPD": "Y"
        },
        {
          "item": "Autoimmune encephalitis is a treatable condition -- recovery may be slow (months to years) but significant improvement is expected with appropriate immunotherapy",
          "ED": "Y",
          "HOSP": "Y",
          "OPD": "Y"
        },
        {
          "item": "Do NOT drive until seizure-free for state-mandated period AND cleared by neurology",
          "ED": "Y",
          "HOSP": "Y",
          "OPD": "Y"
        },
        {
          "item": "Keep seizure diary (date, time, type, duration, triggers)",
          "ED": "-",
          "HOSP": "Y",
          "OPD": "Y"
        },
        {
          "item": "Behavioral and psychiatric symptoms are part of the disease, not a primary psychiatric disorder -- immunotherapy is the treatment",
          "ED": "Y",
          "HOSP": "Y",
          "OPD": "Y"
        },
        {
          "item": "Report any signs of infection (fever >100.4F, cough, dysuria, rash) immediately while on immunotherapy",
          "ED": "-",
          "HOSP": "Y",
          "OPD": "Y"
        },
        {
          "item": "Avoid live vaccines while on immunosuppressive therapy (inform all physicians of immunosuppression status)",
          "ED": "-",
          "HOSP": "Y",
          "OPD": "Y"
        },
        {
          "item": "Do not stop anti-seizure medications abruptly",
          "ED": "-",
          "HOSP": "Y",
          "OPD": "Y"
        },
        {
          "item": "Avoid alcohol and recreational drugs (lower seizure threshold, interact with medications)",
          "ED": "-",
          "HOSP": "Y",
          "OPD": "Y"
        },
        {
          "item": "Pregnancy must be avoided during immunotherapy; discuss contraception with neurology and OB/GYN",
          "ED": "-",
          "HOSP": "Y",
          "OPD": "Y"
        },
        {
          "item": "Expect gradual improvement -- anti-NMDAR recovery typically occurs in reverse order of symptom onset (psychiatric symptoms resolve last)",
          "ED": "-",
          "HOSP": "Y",
          "OPD": "Y"
        },
        {
          "item": "Cognitive rehabilitation exercises as directed by speech and occupational therapy",
          "ED": "-",
          "HOSP": "Y",
          "OPD": "Y"
        },
        {
          "item": "Safety modifications at home (remove sharp objects, secure stairways, fall prevention)",
          "ED": "-",
          "HOSP": "Y",
          "OPD": "Y"
        },
        {
          "item": "Medical alert bracelet recommended (autoimmune encephalitis, seizure risk, immunosuppressed)",
          "ED": "-",
          "HOSP": "Y",
          "OPD": "Y"
        },
        {
          "item": "Follow-up appointments are critical -- relapse monitoring requires regular visits",
          "ED": "-",
          "HOSP": "Y",
          "OPD": "Y"
        }
      ],
      "Tumor Screening Protocols by Antibody": [
        {
          "frequency": "At diagnosis; repeat q6 months x 2 years if initially negative"
        },
        {
          "frequency": "At diagnosis; repeat if relapse"
        },
        {
          "frequency": "At diagnosis; repeat if relapse"
        },
        {
          "frequency": "At diagnosis; q6 months x 4 years"
        },
        {
          "frequency": "At diagnosis; q6 months x 4 years"
        },
        {
          "frequency": "At diagnosis"
        },
        {
          "frequency": "At diagnosis; q6 months x 4 years"
        },
        {
          "frequency": "At diagnosis; q6 months x 4 years"
        },
        {
          "frequency": "At diagnosis; q6 months x 4 years"
        },
        {
          "frequency": "At diagnosis; q6 months x 4 years"
        },
        {
          "frequency": "At diagnosis; repeat if relapse"
        }
      ]
    }
  },
  "differential": [
    {
      "diagnosis": "HSV encephalitis",
      "features": "Acute fever, temporal lobe hemorrhagic necrosis, CSF lymphocytic pleocytosis with RBCs",
      "tests": "HSV PCR (CSF); MRI temporal lobe changes; often more acute onset"
    },
    {
      "diagnosis": "Other viral encephalitis (EBV, CMV, HHV-6, enterovirus, West Nile)",
      "features": "Fever, CSF pleocytosis, specific exposure/season, immunocompromised status",
      "tests": "Specific viral PCR/serology; CSF studies"
    },
    {
      "diagnosis": "Bacterial meningitis/encephalitis",
      "features": "Acute fever, meningismus, CSF neutrophilic pleocytosis, low glucose",
      "tests": "CSF Gram stain, culture, procalcitonin, bacterial PCR"
    },
    {
      "diagnosis": "Neurosyphilis",
      "features": "Cognitive decline, psychiatric symptoms, Argyll Robertson pupils, positive serology",
      "tests": "RPR/VDRL; CSF VDRL; FTA-ABS"
    },
    {
      "diagnosis": "Prion disease (CJD)",
      "features": "Rapidly progressive dementia, myoclonus, akinetic mutism; cortical ribboning on MRI (DWI)",
      "tests": "14-3-3 protein; RT-QuIC; MRI DWI cortical ribboning; EEG periodic discharges"
    },
    {
      "diagnosis": "CNS lymphoma",
      "features": "Progressive encephalopathy, mass lesion, periventricular enhancement, immunocompromised",
      "tests": "CSF cytology/flow cytometry; FDG-PET; brain biopsy"
    },
    {
      "diagnosis": "CNS vasculitis",
      "features": "Headache, stroke-like episodes, multifocal infarcts, elevated ESR/CRP",
      "tests": "Angiography; brain/leptomeningeal biopsy; ESR/CRP"
    },
    {
      "diagnosis": "Neurosarcoidosis",
      "features": "Cranial neuropathies, hypothalamic dysfunction, leptomeningeal enhancement",
      "tests": "ACE level; chest CT (hilar adenopathy); biopsy"
    },
    {
      "diagnosis": "Hashimoto encephalopathy (SREAT)",
      "features": "Encephalopathy with very high anti-TPO; steroid-responsive; diagnosis of exclusion",
      "tests": "Anti-TPO; anti-thyroglobulin; dramatic steroid response"
    },
    {
      "diagnosis": "Acute disseminated encephalomyelitis (ADEM)",
      "features": "Post-infectious/post-vaccination, multifocal large white matter lesions, encephalopathy",
      "tests": "MRI pattern; MOG-IgG; monophasic course"
    },
    {
      "diagnosis": "NMO spectrum disorder (NMOSD)",
      "features": "Optic neuritis, longitudinally extensive myelitis, area postrema syndrome",
      "tests": "AQP4-IgG; MRI pattern"
    },
    {
      "diagnosis": "Drug/toxin-induced encephalopathy",
      "features": "Temporal correlation with drug exposure; resolves with discontinuation",
      "tests": "Urine drug screen; medication review; drug levels"
    },
    {
      "diagnosis": "Metabolic encephalopathy",
      "features": "Hepatic, uremic, thyroid, electrolyte disturbances",
      "tests": "CMP; LFTs; ammonia; TSH; specific metabolic panels"
    },
    {
      "diagnosis": "Psychiatric disorder (new-onset psychosis, catatonia)",
      "features": "No CSF pleocytosis; normal MRI/EEG; isolated psychiatric symptoms (caution: AE can present as pure psychiatric)",
      "tests": "LP mandatory to differentiate; EEG; MRI; antibody testing before assuming primary psychiatric"
    },
    {
      "diagnosis": "Seizure-related encephalopathy (post-ictal/non-convulsive SE)",
      "features": "Prolonged post-ictal confusion; non-convulsive status on EEG",
      "tests": "Continuous EEG monitoring; resolves with ASM treatment"
    },
    {
      "diagnosis": "Neuro-Behcet disease",
      "features": "Oral/genital ulcers; brainstem predominance; CSF neutrophilic pleocytosis",
      "tests": "Clinical criteria; pathergy test; HLA-B51"
    }
  ],
  "evidence": [
    {
      "recommendation": "Graus 2016 diagnostic criteria for autoimmune encephalitis",
      "evidenceLevel": "Expert Consensus, Class III",
      "source": "[Graus F et al. Lancet Neurol 2016;15:391-404](https://pubmed.ncbi.nlm.nih.gov/26906964/)"
    },
    {
      "recommendation": "CSF antibody testing more sensitive than serum for anti-NMDAR",
      "evidenceLevel": "Class II",
      "source": "[Dalmau J et al. Lancet Neurol 2008;7:1091-1098](https://pubmed.ncbi.nlm.nih.gov/18851928/)"
    },
    {
      "recommendation": "Cell-based assay (CBA) is gold standard for antibody detection",
      "evidenceLevel": "Class II",
      "source": "Waters P et al. J Neurol Neurosurg Psychiatry 2014"
    },
    {
      "recommendation": "First-line immunotherapy: IV steroids + IVIG or PLEX",
      "evidenceLevel": "Class III, Expert Consensus",
      "source": "[Titulaer MJ et al. Lancet Neurol 2013;12:157-165](https://pubmed.ncbi.nlm.nih.gov/23290630/)"
    },
    {
      "recommendation": "Early immunotherapy improves outcomes",
      "evidenceLevel": "Class II",
      "source": "[Titulaer MJ et al. Lancet Neurol 2013;12:157-165](https://pubmed.ncbi.nlm.nih.gov/23290630/)"
    },
    {
      "recommendation": "Rituximab as second-line therapy",
      "evidenceLevel": "Class III, Retrospective",
      "source": "[Lee WJ et al. Neurology 2016;86:1683-1691](https://pubmed.ncbi.nlm.nih.gov/27037228/)"
    },
    {
      "recommendation": "Early second-line (rituximab) improves anti-NMDAR outcomes",
      "evidenceLevel": "Class III",
      "source": "[Titulaer MJ et al. Lancet Neurol 2013;12:157-165](https://pubmed.ncbi.nlm.nih.gov/23290630/)"
    },
    {
      "recommendation": "Cyclophosphamide as second-line therapy",
      "evidenceLevel": "Class III, Expert Consensus",
      "source": "[Dalmau J & Graus F. N Engl J Med 2018;378:840-851](https://pubmed.ncbi.nlm.nih.gov/29490181/)"
    },
    {
      "recommendation": "Tocilizumab for refractory autoimmune encephalitis",
      "evidenceLevel": "Class IV, Case Series",
      "source": "[Lee WJ et al. Neurotherapeutics 2016;13:824-832](https://pubmed.ncbi.nlm.nih.gov/27215218/)"
    },
    {
      "recommendation": "Bortezomib for refractory autoimmune encephalitis",
      "evidenceLevel": "Class IV, Case Series",
      "source": "[Scheibe F et al. Neurology 2017;88:366-370](https://pubmed.ncbi.nlm.nih.gov/28003505/)"
    },
    {
      "recommendation": "Ovarian teratoma resection is essential in anti-NMDAR",
      "evidenceLevel": "Class II",
      "source": "[Titulaer MJ et al. Lancet Neurol 2013](https://pubmed.ncbi.nlm.nih.gov/23290630/)"
    },
    {
      "recommendation": "Tumor screening by antibody type",
      "evidenceLevel": "Expert Consensus",
      "source": "[Graus F et al. Lancet Neurol 2016](https://pubmed.ncbi.nlm.nih.gov/26906964/)"
    },
    {
      "recommendation": "Extreme delta brush on EEG in anti-NMDAR",
      "evidenceLevel": "Class III",
      "source": "[Schmitt SE et al. Neurology 2012;79:1094-1100](https://pubmed.ncbi.nlm.nih.gov/22933737/)"
    },
    {
      "recommendation": "Faciobrachial dystonic seizures precede LGI1 encephalitis",
      "evidenceLevel": "Class III",
      "source": "[Irani SR et al. Ann Neurol 2011;69:892-900](https://pubmed.ncbi.nlm.nih.gov/21416487/)"
    },
    {
      "recommendation": "Hyponatremia in LGI1 encephalitis (SIADH mechanism)",
      "evidenceLevel": "Class III",
      "source": "[Lai M et al. Lancet Neurol 2010;9:776-785](https://pubmed.ncbi.nlm.nih.gov/20580615/)"
    },
    {
      "recommendation": "GABA-B encephalitis and SCLC association (~50%)",
      "evidenceLevel": "Class III",
      "source": "[Lancaster E et al. Lancet Neurol 2010;9:67-76](https://pubmed.ncbi.nlm.nih.gov/19962348/)"
    },
    {
      "recommendation": "Anti-NMDAR encephalitis staging and recovery pattern",
      "evidenceLevel": "Class II",
      "source": "[Dalmau J et al. Lancet Neurol 2019;18:1045-1057](https://pubmed.ncbi.nlm.nih.gov/31326280/)"
    },
    {
      "recommendation": "Modified Rankin Scale for outcome tracking",
      "evidenceLevel": "Validated Scale",
      "source": "[van Swieten JC et al. Stroke 1988;19:604-607](https://pubmed.ncbi.nlm.nih.gov/3363593/)"
    },
    {
      "recommendation": "CASE score for autoimmune encephalitis assessment",
      "evidenceLevel": "Validated Scale",
      "source": "[Lim JA et al. Ann Neurol 2019;85:352-358](https://pubmed.ncbi.nlm.nih.gov/30675918/)"
    },
    {
      "recommendation": "Catatonia in anti-NMDAR encephalitis (~40%)",
      "evidenceLevel": "Class III",
      "source": "[Al-Diwani A et al. Lancet Psychiatry 2019;6:235-246](https://pubmed.ncbi.nlm.nih.gov/30765329/)"
    },
    {
      "recommendation": "Lorazepam challenge for catatonia",
      "evidenceLevel": "Expert Consensus",
      "source": "[Bush G et al. Acta Psychiatr Scand 1996;93:129-136](https://pubmed.ncbi.nlm.nih.gov/8686483/)"
    },
    {
      "recommendation": "NMS risk with antipsychotics in anti-NMDAR",
      "evidenceLevel": "Class IV, Case Reports",
      "source": "[Lejuste F et al. Neurol Neuroimmunol Neuroinflamm 2016;3:e280](https://pubmed.ncbi.nlm.nih.gov/27606355/)"
    },
    {
      "recommendation": "Levetiracetam as preferred ASM in autoimmune encephalitis",
      "evidenceLevel": "Expert Consensus",
      "source": "[Britton J. Handb Clin Neurol 2016;133:219-245](https://pubmed.ncbi.nlm.nih.gov/27112680/)"
    },
    {
      "recommendation": "Avoid carbamazepine in LGI1 (worsens hyponatremia)",
      "evidenceLevel": "Expert Consensus",
      "source": "[Irani SR et al. Brain 2010;133:2734-2748](https://pubmed.ncbi.nlm.nih.gov/20663977/)"
    },
    {
      "recommendation": "Long-term rituximab maintenance prevents relapse",
      "evidenceLevel": "Class III",
      "source": "[Nosadini M et al. Expert Rev Neurother 2015;15:1391-1419](https://pubmed.ncbi.nlm.nih.gov/26559389/)"
    },
    {
      "recommendation": "Anti-NMDAR relapse rate 12-20%",
      "evidenceLevel": "Class II",
      "source": "[Titulaer MJ et al. Lancet Neurol 2013](https://pubmed.ncbi.nlm.nih.gov/23290630/)"
    },
    {
      "recommendation": "Mycophenolate as steroid-sparing agent",
      "evidenceLevel": "Class IV",
      "source": "Expert practice; no large trials"
    },
    {
      "recommendation": "Autonomic instability management in anti-NMDAR",
      "evidenceLevel": "Expert Consensus",
      "source": "[Dalmau J & Graus F. N Engl J Med 2018](https://pubmed.ncbi.nlm.nih.gov/29490181/)"
    },
    {
      "recommendation": "Repeat tumor screening q6 months x 2-4 years",
      "evidenceLevel": "Expert Consensus",
      "source": "[Graus F et al. Lancet Neurol 2016](https://pubmed.ncbi.nlm.nih.gov/26906964/)"
    },
    {
      "recommendation": "Central hypoventilation in severe anti-NMDAR requiring prolonged ventilation",
      "evidenceLevel": "Class III",
      "source": "[Florance NR et al. Ann Neurol 2009;66:11-18](https://pubmed.ncbi.nlm.nih.gov/19670433/)"
    },
    {
      "recommendation": "Neuropsychological recovery trajectory in autoimmune encephalitis",
      "evidenceLevel": "Class III",
      "source": "[Finke C et al. JAMA Neurol 2017;74:50-59](https://pubmed.ncbi.nlm.nih.gov/27893017/)"
    }
  ],
  "monitoring": [
    {
      "item": "Neurologic examination (GCS, orientation, cranial nerves, motor, reflexes)",
      "frequency": "Q4-6h (ICU); Q8-12h (floor)",
      "action": "If worsening: urgent re-imaging; escalate immunotherapy; consider ICU transfer"
    },
    {
      "item": "Modified Rankin Scale (mRS)",
      "frequency": "Baseline, then weekly",
      "action": "Document trajectory; guide treatment escalation; long-term disability tracking"
    },
    {
      "item": "Bush-Francis Catatonia Rating Scale",
      "frequency": "Daily if catatonia features",
      "action": "If not responding to lorazepam: increase dose; consider ECT; escalate immunotherapy"
    },
    {
      "item": "Blood glucose",
      "frequency": "Q6h during IV steroids",
      "action": "Insulin sliding scale; endocrine consult if persistent >250"
    },
    {
      "item": "Blood pressure",
      "frequency": "Q1h (ICU); Q4h (floor)",
      "action": "Autonomic dysregulation: labetalol/esmolol for hypertension; norepinephrine for hypotension"
    },
    {
      "item": "Heart rate and rhythm",
      "frequency": "Continuous telemetry (ICU/floor)",
      "action": "Autonomic instability: treat per protocol (3F); cardiology consult if sustained arrhythmia"
    },
    {
      "item": "Temperature",
      "frequency": "Q4h; continuous in ICU",
      "action": "Central hyperthermia: cooling measures; acetaminophen; rule out infection"
    },
    {
      "item": "Respiratory rate and NIF",
      "frequency": "Q4h (ICU); Q shift (floor)",
      "action": "NIF worsening toward -20: intubation; ICU transfer; evaluate for neuromuscular respiratory failure"
    },
    {
      "item": "Seizure log",
      "frequency": "Continuous",
      "action": "If increasing: escalate ASMs; re-assess immunotherapy; continuous EEG"
    },
    {
      "item": "EEG (continuous)",
      "frequency": "24-72h minimum; longer if ICU",
      "action": "If persistent seizures: escalate per Section 3D"
    },
    {
      "item": "Sodium (Na)",
      "frequency": "Q6-12h (if LGI1 or hyponatremia)",
      "action": "Correct per protocol (3F); fluid restriction if SIADH"
    },
    {
      "item": "I/O and daily weight",
      "frequency": "Daily",
      "action": "Adjust fluids; diuretics if fluid overload; free water restriction if SIADH"
    },
    {
      "item": "Renal function (BUN/Cr)",
      "frequency": "Daily during IVIG; q48h otherwise",
      "action": "Hold IVIG if Cr rising; hydration; nephrology consult"
    },
    {
      "item": "CBC with differential",
      "frequency": "Q48h during immunotherapy; daily if on cyclophosphamide",
      "action": "Hold immunotherapy if critically low; growth factor support; hematology consult"
    },
    {
      "item": "LFTs",
      "frequency": "Q48-72h during acute treatment",
      "action": "Dose adjustment or hold hepatotoxic medications"
    },
    {
      "item": "Fibrinogen (during PLEX)",
      "frequency": "Before each exchange",
      "action": "Hold PLEX if <100; FFP replacement"
    },
    {
      "item": "Neurologic examination (cognition, behavior, seizures, motor)",
      "frequency": "Monthly x 6 months; then q3 months x 2 years; then q6 months",
      "action": "If relapse: repeat LP/MRI; resume or escalate immunotherapy; re-screen for tumor"
    },
    {
      "item": "Modified Rankin Scale (mRS)",
      "frequency": "Each visit",
      "action": "Document trajectory; adjust rehab goals; consider treatment escalation if plateau or decline"
    },
    {
      "item": "CASE score (Clinical Assessment Scale in Autoimmune Encephalitis)",
      "frequency": "Each visit",
      "action": "Standardized outcome measure; guide treatment decisions"
    },
    {
      "item": "MRI brain with and without contrast",
      "frequency": "3-6 months post-treatment; then annually x 3 years",
      "action": "New/worsening lesions: relapse workup; repeat antibody testing; escalate treatment"
    },
    {
      "item": "EEG (routine)",
      "frequency": "3-6 months post-treatment; as needed for seizure management",
      "action": "If persistent abnormality: continue/adjust ASMs; consider repeat immunotherapy"
    },
    {
      "item": "Serum antibody titers",
      "frequency": "q3-6 months x 2 years; then annually",
      "action": "Rising titers may precede clinical relapse; increase surveillance; consider preemptive treatment"
    },
    {
      "item": "CBC with differential",
      "frequency": "Q2-4 weeks on mycophenolate/azathioprine; then monthly",
      "action": "Hold/reduce immunosuppression; growth factor support"
    },
    {
      "item": "LFTs",
      "frequency": "Monthly x 3 months on azathioprine/mycophenolate; then q3 months",
      "action": "Dose reduction or switch agent"
    },
    {
      "item": "Immunoglobulin levels (IgG, IgA, IgM)",
      "frequency": "Q3-6 months on rituximab or other B-cell depletion",
      "action": "Immunoglobulin replacement if recurrent infections with hypogammaglobulinemia"
    },
    {
      "item": "CD19/CD20 B-cell counts",
      "frequency": "Q3 months on rituximab",
      "action": "Guide re-dosing interval; B-cell repopulation may trigger relapse"
    },
    {
      "item": "TPMT activity/genotype",
      "frequency": "Once before starting azathioprine",
      "action": "Dose reduce or avoid azathioprine if intermediate/low TPMT"
    },
    {
      "item": "Tumor surveillance (per antibody type -- Section 4C)",
      "frequency": "Per protocol: q6 months x 2-4 years",
      "action": "If tumor found: urgent oncology referral and surgical resection"
    },
    {
      "item": "Neuropsychological testing",
      "frequency": "Baseline (when able); 6 months; 12 months; annually",
      "action": "Guide cognitive rehabilitation; inform return to work/school planning"
    },
    {
      "item": "DEXA scan (bone density)",
      "frequency": "Baseline if steroids >3 months; repeat q1-2 years",
      "action": "Bisphosphonate therapy; calcium/vitamin D optimization"
    },
    {
      "item": "ASM drug levels (if applicable)",
      "frequency": "Per drug-specific schedule; after dose changes",
      "action": "Adjust dose; assess adherence"
    }
  ],
  "disposition": [
    {
      "disposition": "**Discharge home**",
      "criteria": "Mild symptoms; stable or improving on established immunotherapy; no active seizures; able to perform basic ADLs; reliable follow-up within 1-2 weeks; no significant autonomic instability; family/caregiver education completed; outpatient infusion arranged if needed"
    },
    {
      "disposition": "**Admit to floor (medical/neurology)**",
      "criteria": "New-onset encephalitis requiring workup and immunotherapy initiation; seizures requiring medication adjustment; moderate behavioral symptoms manageable on floor; needs IV steroids/IVIG; diagnostic uncertainty requiring expedited workup"
    },
    {
      "disposition": "**Admit to ICU**",
      "criteria": "Refractory status epilepticus; altered consciousness (GCS <12); severe autonomic instability (hemodynamic swings, arrhythmias, central hypoventilation); need for continuous EEG monitoring; requirement for mechanical ventilation; severe catatonia unresponsive to lorazepam; frequent or prolonged seizures requiring IV anesthetic infusions"
    },
    {
      "disposition": "**Transfer to higher level of care**",
      "criteria": "PLEX or continuous EEG not available; neurology/neuroimmunology specialist not available; need for tumor resection (gynecologic oncology for teratoma); requires ICU care not available at current facility"
    },
    {
      "disposition": "**Inpatient rehabilitation**",
      "criteria": "Medically stable; significant functional deficits requiring intensive therapy (cognitive, motor, speech); unable to safely return home; expected to benefit from structured rehabilitation program"
    },
    {
      "disposition": "**Long-term acute care (LTAC)**",
      "criteria": "Prolonged ventilator dependence (common in severe anti-NMDAR); medically complex care needs; ongoing immunotherapy requirements; unable to participate in intensive rehab"
    },
    {
      "disposition": "**Skilled nursing facility**",
      "criteria": "Stable but unable to perform ADLs independently; requires ongoing nursing care; awaiting rehabilitation bed; chronic disability"
    },
    {
      "disposition": "**Outpatient follow-up**",
      "criteria": "All discharged patients: neurology follow-up within 1-2 weeks; infusion center for ongoing immunotherapy; neuropsychology referral; rehab services; tumor surveillance per protocol"
    },
    {
      "disposition": "**Readmission criteria**",
      "criteria": "New seizures after period of control; behavioral/cognitive regression; fever or signs of infection on immunotherapy; suspected relapse (any new neurologic/psychiatric symptoms)"
    }
  ]
}
